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ABSTRACT
Verbal and Visual Learning and Memory Deficits as Trait Markers for Psychosis in
Bipolar Disorder
by
Griffin P. Sutton, B.A.
Dr. Daniel N. Allen, Examination Committee Chair
Professor of Psychology
University of Nevada, Las Vegas
The presence of neurocognitive deficits in the affective and psychotic psychiatric
disorders (i.e., bipolar disorder with psychotic features, bipolar disorder without
psychotic features, and schizophrenia) has been well documented, with such these
deficits having been found to overlap across these diagnostic categories to a degree.
Along with other types of evidence reported, these findings suggest that bipolar disorder
and schizophrenia may not be isolated disorders as suggested by the current diagnostic
criteria outlined in the DSM-IV (APA, 1994), but rather may be related disorders on a
spectrum marked by bipolar disorder without psychosis on one end and by schizophrenia
on the other end, with bipolar disorder with psychosis and schizoaffective disorder
occupying the middle of the spectrum, an idea known as the spectrum hypothesis.
The purpose of this study was primarily to examine the presence of and, if
relevant, severity of verbal and visual learning and memory impairments in individuals
with bipolar disorder with and without psychotic features. A secondary purpose of this
study was to examine, if present, the severity of these same neurocognitive impairments
in individuals with schizophrenia, who were included as a validity check for the expected
spectrum of performance across the groups. It was anticipated that impairments would be
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identified that would not only provide support for the spectrum hypothesis, but would
also differentiate between psychiatric disorders with and without psychotic features.
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CHAPTER 1
INTRODUCTION
Comparisons between bipolar disorder and psychotic disorders such as
schizophrenia have long been explored. Similarities between the disorders have been
repeatedly noted, including the neuropsychological profiles of the disorders (e.g., Hoff et
al., 1990), although some differences have been noted as well (e.g., Mojtabai et al., 2000).
Furthermore, comparisons between the two disorders have demonstrated that despite their
similarities, schizophrenia often tends to be associated with more severe premorbid
impairment, including social withdrawal (e.g., McClellan & McCurry, 1999), as well as
more severe neurocognitive impairments (Gruzelier, Seymour, Wilson, Jolley, & Hirsch,
1988; Mojtabai et al., 2000; Dickerson et al., 2004).
Much debate currently exists regarding whether bipolar disorder, schizoaffective
disorder, and schizophrenia represent distinct diagnostic categories or would be better
conceptualized as falling along a spectrum which is bound by affective disorder on one
end and schizophrenia at the other, with schizoaffective disorder assuming a position
intermediate to the other two (Averill et al, 2004). If these two disorders do fall along a
spectrum, then a number of predictions could subsequently be made. For example, it
would be expected that they share symptoms, as a number of studies suggest have
suggested (e.g., Toomey, Faraone, Simpson, & Tsuang, 1998; Strakowski, 2003).
Furthermore, it would be expected that there would be some instances of a change in
diagnostic category (e.g., Laursen et al., 2005), as well as evidence of shared genetic
vulnerability (Gershon et al., 1982; Bertelsen & Gottesman, 1995; Berrettini, 2000;
Laursen et al., 2005; Ghaemi et al., 2008). Finally, shared neurocognitive deficits should

1

be identified if such a spectrum were to exist (Beatty, Jocic, Monson, & Staton, 1993;
Albus, Hubmann, Walheim, et al., 1996; Goldstein, Shemansky, & Allen, 2005).
The current study investigated the hypothesis of shared neurocognitive deficits by
comparing two patient groups (i.e., bipolar disorder with and without psychotic features)
to normal controls on measures of verbal and nonverbal (i.e., visual) memory, which
have been identified as key neurocognitive domains in both affective and psychotic
disorders. Additionally, a number of secondary comparisons were made with patients
diagnosed with schizophrenia to further examine the role of psychotic features in memory
functioning, and thus to explore in more depth the idea that schizophrenia and bipolar
disorder with psychotic features are not isolated from one another, but are rather
connected by some underlying factor perhaps associated with psychosis.
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CHAPTER 2
LITERATURE REVIEW
The Spectrum Hypothesis
There are a number of various possible symptom combinations that warrant a
diagnosis of bipolar disorder (BP), and thus a great deal of heterogeneity in the
expression of the disorder. Specifically, there are more than 5 billion combinations of
symptoms that can lead to a diagnosis of bipolar disorder when all of the specifiers listed
in the DSM-IV are considered (Lieberman, Peele, & Razavi, 2008). As a result, many
have posited the idea that the diagnostic criteria should be changed – that perhaps we are
conceptualizing BP and its associated symptoms in an incorrect manner (e.g., Lieberman
et al., 2008). In fact, the Diagnostic Guidelines Task Force has suggested that
schizoaffective disorder be dropped from the DSM-V altogether (Ghaemi et al., 2008),
while others have advocated a move away from the Kraepelinian dichotomy of affective
and psychotic disorders (Craddock & Owen, 2005). One proposal which has resulted
from research regarding the presence of psychosis and corresponding neurocognitive
deficits in BP is the possibility of a spectrum of disorders, such that affective disorders
and psychotic disorders are not separate diagnostic categories, but rather may represent a
spectrum of disorders bounded on one side by schizophrenia, and on the other by BP,
with schizoaffective disorder and bipolar disorder with psychotic features assuming
intermediate positions on the spectrum (Laursen et al., 2005; Lake & Hurwitz, 2007;
Cheniaux et al., 2008; Peralta & Cuesta, 2008; Ghaemi et al., 2008). And yet some
others disagree (e.g., Evans et al., 1999). Nevertheless, a change in diagnostic criteria
could allow for more flexibility in making diagnoses (i.e., by using such diagnostic terms
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as “psychosis-spectrum illness” or “mood-reality disorder”), and thus address the conflict
inherent in drawing distinctions between disorders that share many symptoms in common.
It may also assist in avoiding damage done to the therapeutic relationship when clinicians
and psychiatrists are uncertain which diagnosis to make and/or when there is a change in
diagnoses over time (Craddock & Owen, 2005). Such a change could also help
accurately determine which treatment approach(es) may be most appropriate for
individuals, as different treatment approaches may vary in efficacy according to different
diagnoses. If the hypothesis that a spectrum exists is correct, then several subsequent
hypotheses can be posited, including: 1) temporal instability of diagnoses that are made
based on the current DSM-IV nomenclature; 2) the presence of evidence supporting
shared genetic vulnerability; 3) an overlap in symptoms, epidemiology, and clinical
expression; and, 4) patterns of neurocognitive deficits that suggest similarities in brain
dysfunction across diagnostic categories.
Temporal Instability of Diagnostic Categories
With regard to temporal instability of diagnoses, if the spectrum hypothesis is
valid, then there should be reports of individuals who were originally diagnosed with
schizophrenia, schizoaffective disorder, or an affective disorder (i.e., BP or major
depressive disorder), but then later received one of the other diagnoses due to emerging
or worsening (or, in some cases, resolving) symptomatology. These changes could
reflect true psychiatric changes within the individual, factors related to disease course,
individual differences in the diagnostic decision-making of clinicians, or some
combination of these factors. However, these changes could also result from the use of
faulty diagnostic criteria, with the error lying in the separation of the two disorders (i.e.,
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BP and schizophrenia) rather than the consideration of the two disorders as lying on the
same spectrum. Such findings have, in fact, been reported. Laursen and colleagues
(2005), for example, found that more than half (specifically, 51% of females and 58% of
males) of a large group of individuals who were diagnosed with schizoaffective disorder
had been previously diagnosed with either BP or schizophrenia. Moreover, studies have
repeatedly reported evidence of a subgroup of individuals with schizophrenia (as many as
approximately 70% of cases examined) whose path towards a psychiatric diagnosis
originally began with depression (Koreen et al., 1993; H fner, Loffler, Maurer,
Hambrecht, & an der Heiden, 1999). At least one other study, however, found diagnoses
of schizophrenia, bipolar disorder, and schizoaffective disorder to be relatively stable
over time (McClellan & McCurry, 1999). Research in this area has thus yielded mixed
results.
Shared Genetic Vulnerability
A second subsequent hypothesis regards shared heritability, such that there should
be some overlap in genetic vulnerability to schizoaffective disorder in groups of
individuals with BP and schizophrenia. Berrettini (2000) reported evidence from a
review of studies indicating that first-degree relatives of individuals with BP have been
found to have an increased risk of bipolar I disorder, bipolar II disorder, schizoaffective
disorder, and recurrent unipolar disorder, while other studies have found first-degree
relatives of individuals with schizophrenia to have an increased risk for schizophrenia,
schizoaffective disorder, and recurrent unipolar disorder. Taken together, this evidence
does suggest a common increase in risk for schizoaffective disorder in the first-degree
relatives of both individuals with BP and individuals with schizophrenia. Additionally,
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genetic linkage studies have found several susceptibility loci which are common for both
BP and schizophrenia, as well as several which are unique to these disorders (Berrettini,
2000; Baum et al., 2008). Overall, after reviewing the evidence Berrettini (2000)
suggests that bipolar and schizophrenia share similarities, especially in individuals’
genetic susceptibility to developing either of the disorders.
Furthermore, Laursen and colleagues (2005) examined the prevalence rates of BP,
schizophrenia, and schizoaffective disorder in the citizens of Denmark who had been
born after 1952. Participants’ individual and family histories and diagnoses were
examined, and cumulative incidence rates calculated. For BP, there was a 3.36%
cumulative incidence of the disorder when there was a family history of hospitalization
due to BP (as opposed to a 0.31% cumulative incidence when there was no such history),
a 2.88% cumulative incidence of the disorder when there was a family history of
schizoaffective disorder (as opposed to a 0.32% cumulative incidence when there was no
such history), and a 1.20% cumulative incidence of the disorder when there as a family
history of schizophrenia (as opposed to a 0.32% cumulative incidence when there was no
such history). For schizoaffective disorder, there was a 1.84% cumulative incidence
when there was a family history of schizoaffective disorder (as opposed to a 0.16%
cumulative incidence when there was no such history), a 1.47% cumulative incidence
when there was a family history of bipolar disorder (as opposed to a 0.16% cumulative
incidence when there was no such history), and a 1.16% cumulative incidence when there
was a family history of schizophrenia (as opposed to a 0.16% cumulative incidence when
there was no such history). Finally, for schizophrenia, there was a 6.11% cumulative
incidence when there was a family history of schizophrenia (as opposed to a 0.88%
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cumulative incidence when there was no such history), a 3.64% cumulative incidence
when there was a family history of schizoaffective disorder (as opposed to a 0.92%
cumulative incidence when there was no such history), and a 3.22% cumulative incidence
when there was a family history of bipolar disorder (as opposed to a 0.91% cumulative
incidence when there was no such history). Overall, these results indicate that there is an
increase in risk for developing each of these disorders (i.e., BP, schizoaffective disorder,
and schizophrenia) when there is a family history of any of the disorders as compared to
when there is no such family history, thus suggesting an overlap in genetic vulnerability
among the disorders.
Similarly, Angst, Frey, Lohmeyer, and Zerbin-Rüdin (1980) followed a group of
individuals with BP (n = 95) and their first-degree relatives (n = 617) for 16 years and
found an risk of schizophrenia (1.9±0.6%) and schizoaffective disorder (1.5±0.5%) in the
families of the BP group as compared to the normal population. These increased risks,
however, were slight and not statistically significant.
Tsuang (1991) also collected diagnostic information from the first-degree
relatives of a large group of individuals suffering from either schizophrenia (n = 200), BP
(n = 300), unipolar depression (n = 225), or schizoaffective disorder (n = 57). The
morbidity risks for the first-degree relatives of the patients were reported as follows: for
the first-degree relatives of individuals in the schizoaffective disorder group, there was a
6.6% morbidity risk for schizophrenia and a 13.0% morbidity risk for affective disorder;
for the first-degree relatives of individuals in the schizophrenia group, there was a 5.5%
morbidity risk for schizophrenia and a 10.1% morbidity risk for an affective disorder; and,
for the first-degree relatives of individuals in either of the affective disorder groups, there
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was a 2.2% morbidity risk for schizophrenia and an 18.1% morbidity risk for an affective
disorder. These are greater than the reported morbidity risk statistics for BP (1.8%;
Weissman, Kidd, & Prusoff, 1982) and schizophrenia (0.3%; Baron, Gruen, Kane, &
Asnis, 1985); no such data could be located for schizoaffective disorder. These
similarities in increased morbidity risk across disorders are further indicative of the
possible overlap in genetic heritability among individuals suffering from these disorders.
Gershon and colleagues (1982) similarly reported that the relatives of individuals
with schizoaffective disorder were found to have significantly greater prevalence rates of
affective disorders (including schizoaffective disorder) and schizophrenia than the
relatives of individuals with other Axis I (e.g., generalized anxiety disorder, obsessivecompulsive disorder, etc.) or Axis II (e.g., antisocial personality disorder, etc.) disorders.
Similarities in Symptoms, Epidemiology, and Clinical Expression
Similar to shared heritability, individuals with these disorders should demonstrate
some degree of shared epidemiology and symptomatology if the spectrum hypothesis is
true. Regarding shared epidemiology, Berrettini (2000) and Maier, Zobel, & Wagner
(2006) each identified commonalities between BP and schizophrenia in prevalence rate,
age of onset (typically before age 25, but not prior to puberty), the presence of psychosis
in a subset of individuals, the improbability of a full remission once a diagnosis has been
made, increased risk of suicide, familial aggregation, and degree of heritability as
measured and estimated from twin studies (approximately 65% for BP versus
approximately 50% for schizophrenia). Marneros, Roettig, Roettig, Tscharntke, and
Brieger (2008) similarly found that only approximately one-third of a group of
individuals with BP (n = 182) had a history of only mood episodes; the remaining two-
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thirds reported a history of at least one schizophreniform or schizoaffective episode, thus
providing further evidence suggesting that BP lies on a spectrum with schizoaffective
disorder and schizophrenia.
Furthermore, if these psychiatric disorders are related, then other clinical features,
should also be similar at least for subgroups of patients in the different diagnostic
categories. In this vein, Angst, Sellaro, Stassen, and Gamma (2005) reported that 50% of
a group of individuals with BP studied both retrospectively and prospectively initially
met criteria and/or received a diagnosis of unipolar depression. Similarly, H fner and
colleagues (2005) found that, when interviewed retrospectively, 83% of a group of
individuals hospitalized for schizophrenia had had at least one major depressive episode
in their lifetime. Moreover, the most common initial symptom of schizophrenia was a
depressive mood, followed by the presence of negative symptoms and functional
impairment. In fact, both the schizophrenia group and a comparison unipolar depression
group reported prodromal symptoms of depression, including nervousness/restlessness
(occurring in 88.3% of the schizophrenia group and 81.5% of the depression group),
anxiety (occurring in 88.1% of the schizophrenia group and 81.5% of the depression
group), difficulties in thinking/concentration (occurring in 93.8% of the schizophrenia
group and 96.9% of the depression group), disturbed appetite and/or sleep (occurring in
93.8% of the schizophrenia group and 98.5% of the depression group), irritability
(occurring in 65.4% of the schizophrenia group and 68.5% of the depression group), and
dissocial behavior (occurring in 15.3% of the schizophrenia group and 14.6% of the
depression group).
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Similarly, Maj, Pirozzi, Formicola, Bartoli, and Bucci (2000) examined the
reliability and validity of the diagnosis of schizoaffective disorder as compared to
schizophrenia and schizophreniform disorder. All participants were diagnosed based on
DSM-IV criteria (APA, 1994) and were diagnosed a second time 2 years later by a
psychiatrist who was blind to the previous diagnosis. The diagnosis of schizoaffective
disorder was found to be unreliable, as the symptoms upon which the schizoaffective
disorder diagnoses were based could also have been considered to be indicative of the
presence of either a mood episode or schizophrenia.
Patterns of Neurocognitive Deficits
Finally, if the spectrum hypothesis is accurate, research comparing BP,
schizoaffective disorder, and schizophrenia would be expected to yield evidence of
neurocognitive impairments which are more severe, if not unique, in individuals
diagnosed with psychiatric illnesses with psychotic features as compared to those without
psychotic features. However, results of such research have been mixed, as some have
found no evidence of such differences (Miller, Swanson-Green, Moses, & Faustman,
1996).
Conversely, Goldstein, Shemansky, and Allen (2005) compared the
neuropsychological performance of groups of males with schizophrenia (n = 63) and
schizoaffective disorder (n = 20). The schizoaffective disorder group and the subgroup of
individuals with paranoid schizophrenia exhibited significantly less overall
neurocognitive impairment than did those with undifferentiated and residual
schizophrenia. More importantly, the researchers suggested that the neuropsychological
profile of a subgroup of individuals with schizoaffective disorder may resemble that of
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individuals with non-psychotic major depressive disorder and/or BP. While these
findings are by no means definitive, they are a step in the direction of support for the
spectrum hypothesis, such that schizoaffective disorder seems to epitomize a disorder
which falls between schizophrenia and BP on the spectrum.
Beatty, Jocic, Monson, and Staton (1993) similarly evaluated groups of
individuals with schizophrenia (n = 13) and schizoaffective disorder (n = 13), with no
significant difference in medication use between the two groups, as well as a group of
normal controls (n = 20) and found both similarities and differences in the cognitive
impairments of the schizophrenia and schizoaffective groups. Specifically, both groups
were found to be significantly impaired as compared to the normal controls in the
domains of attention, problem solving, and verbal and nonverbal fluency, with no
significant differences in performance between the groups. Regarding verbal learning
and memory, however, the two groups performed somewhat differently. While both
groups demonstrated significant impairment in the area of verbal recall, but not in that of
recognition, the schizophrenia group exhibited significantly more rapid forgetting than
either of the other two groups. The results of the study therefore suggest that relative
verbal learning and memory impairments may be a distinguishing factor between
individuals with schizophrenia and those with schizoaffective disorder, with patterns of
neurocognitive impairment being similar in other neurocognitive domains for the two
groups.
McClellan, Prezbindowski, Breiger, and McCurry (2002) also compared the
neuropsychological profiles of groups of adolescents who had been diagnosed with
schizophrenia (n = 27), bipolar disorder (n = 22), or psychosis not otherwise specified (n
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= 20). Participants were administered a neuropsychological battery which included
measures of intelligence, executive function, verbal learning and memory, visual learning,
and visual motor integration. All three psychiatric groups were found to be significantly
impaired in the areas of attention and verbal learning and memory. No significant
differences were found between any of the groups in any of the neurocognitive domains,
suggesting that the neurocognitive impairments accompanying schizophrenia and bipolar
disorder may be very similar in at least some neurocognitive domains.
Albus, Hubmann, Walheim, and colleagues (1996) also compared the
neuropsychological performance of a group of individuals suffering from first-episode
schizophrenia (n = 27), a group of individuals suffering from either first-episode unipolar
depression (n = 10) or first-episode BP (n = 17), some with psychotic features (n = 11)
and some without (n = 16), as well as a group of normal controls (n = 27). Results
indicated that all three psychiatric groups performed significantly worse than the control
group in the areas of verbal learning and memory. Interestingly, the affective disorders
with psychosis subgroup performed no differently than the schizophrenia group in the
neurocognitive domains of visual motor processing and attention, while the affective
disorders without psychosis subgroup performed no differently than the normal control
group.
Finally, Smith, Barch, and Csernansky (2009) compared the neuropsychological
performance of groups of individuals with either schizophrenia (n = 72) or a psychotic
mood disorder (i.e., schizoaffective disorder or bipolar disorder with psychotic features; n
= 25) to a group of normal controls (n = 72). Participants were assessed in the
neurocognitive domains of crystallized intelligence, working memory, episodic memory,
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and executive functioning. Both psychiatric groups were found to be significantly
impaired as compared to the normal controls in the areas of working memory, episodic
memory, and executive functioning. Furthermore, there were no significant differences
between the psychiatric groups in these domains, suggesting similar neuropsychological
impairments in the schizophrenia, schizoaffective, and bipolar groups. With regard to
intelligence, the schizophrenia group was found to be significantly impaired as compared
to both the psychotic mood disorder and normal control groups, who in turn performed
similarly to one another.
On the other hand, Reichenberg and colleagues (2008) did find differences in the
neuropsychological profiles of individuals with schizophrenia versus other psychotic
disorders. Specifically, the researchers administered a neuropsychological battery of
eight neurocognitive domains (i.e., general verbal ability, verbal declarative memory,
visual declarative memory, abstraction-executive function, attention and processing speed,
simple motor skills, visual processing, and language ability) to groups of individuals
diagnosed with schizophrenia (n = 94), schizoaffective disorder (n = 15), bipolar
disorder (n = 78), and major depressive disorder (n = 48). Results indicated that all four
psychiatric groups were significantly impaired in the neurocognitive domains of verbal
and visual declarative memory, executive function, and attention and processing speed.
The schizophrenia group, however, demonstrated significantly greater impairment across
all of the domains, suggesting that schizophrenia may be accompanied by more severe
cognitive deficits, at least in the neurocognitive domains examined in this study.
If the spectrum hypothesis is valid, there should also be observed differences in
neurocognitive impairment between individuals suffering from disorders with and

13

without psychotic features, as well as similarities in neurocognitive impairment in
disorders with psychotic features. Glahn, Bearden, and colleagues (2006), for example,
evaluated working memory performance in groups of individuals with schizophrenia (n =
15), schizoaffective disorder (n = 15), BP with psychotic features (n = 11), and BP
without psychotic features (n = 15), as well as a group of normal controls (n = 32). As
compared to normal controls, all patient groups demonstrated significant impairment on
Digit Span Backward. Furthermore, the psychosis groups (i.e., the BP with psychotic
features, schizoaffective, and schizophrenia groups) were found to be significantly
impaired on both Digit Span Forward and the spatial delayed response task (DRT).
Group comparisons indicated no significant differences in neuropsychological
performance between the BP with psychotic features and schizoaffective groups, or
between the schizoaffective and schizophrenia groups, suggesting similar working
memory deficits in the three psychosis groups.
The Spectrum Hypothesis: Conclusion
Overall, the results of diagnostic, genetic, epidemiological, clinical and
neurocognitive studies support the hypothesis that affective disorders are better
conceptualized as lying along a spectrum (as opposed to discrete diagnostic entities). For
BP, the results also indicate that the presence of psychosis is an indicator of more severe
neurocognitive impairment, at least in the area of working memory, as compared to the
neurocognitive impairments observed in individuals with psychiatric diagnoses without
concomitant psychotic features.
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Bipolar Disorder
Characteristics of Bipolar Disorder
Bipolar disorder (BP) is a debilitating mood disorder with a community lifetime
prevalence of 0.4-1.6% as reported by the DSM-IV (APA, 1994). Similarly, a recent
epidemiological study reported a lifetime prevalence rate of 1.0% for bipolar I disorder
and 1.1% for bipolar II disorder, and a 12-month prevalence rate of 0.6% and 0.8% for
the disorders, respectively (Merikangas et al., 2007). Lifetime prevalence estimates from
other countries have ranged from 0.5% to 5.1% in such areas as The Netherlands, Europe,
Australia, and Hungary (Lewinsohn, Klein, & Seeley, 1995; Szádóczky, Papp, Vitrai,
Ríhmer, & Füredi, 1998; Ten Have, Vollebergh, Bijl, & Nolen, 2002; Regeer et al., 2004;
Goldney, Fisher, Dal Grande, Taylor, & Hawthorne, 2005; Pini et al., 2005), with
Hungary reporting the highest lifetime prevalence at 5.1% (Szádóczky et al., 1998).
BP is a severe mental disorder which is often accompanied by significant
psychosocial and occupational impairment, and for which hospitalization is often
necessary (Mansell & Pedley, 2008). BP is characterized by the occurrence of manic,
major depressive, and/or mixed mood episodes. While the presence of a single manic or
mixed episode necessitates a diagnosis of BP, the typical BP patient experiences affective
oscillations between depressive and manic episodes, often with interepisode periods of
euthymia.
Manic episodes are primarily characterized by periods of euphoria and/or
irritability accompanied by a combination of other symptoms, including feelings of
grandiosity, a decreased need for sleep, an increase in speech (in both amount and speed),
racing thoughts, distractibility, an increase in goal-directed activity, inappropriate
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involvement in activities which may lead to dangerous and/or painful consequences, and
in some cases, psychosis (APA, 1994). Symptoms must occur simultaneously for at least
a week, unless hospitalization is necessary to regulate symptoms. As many as 70% of
manic episodes may be severe (as defined by a Young Mania Scale rating of ≥25), with
the majority of the remaining episodes being classified as mild (as defined by a Young
Mania Scale rating of 9-14) to moderate (as defined by a Young Mania Scale rating of 610; Merikangas et al., 2007).
Conversely, major depressive episodes are characterized by periods of depressed
mood and/or anhedonia accompanied by a variety of co-occurring symptoms, including
significant weight loss or weight gain, hypersomnia or insomnia, psychomotor agitation
or psychomotor retardation, fatigue, feelings of worthlessness, excessive or inappropriate
guilt, diminished ability to think or concentrate, indecisiveness, recurrent thoughts of
death, plans for suicide, and/or suicide attempts (APA, 1994). A review by Goodwin and
Jamison (1990) reported a lifetime suicide rate of 19% in individuals suffering from
“major mood disorders”, which included major depressive and bipolar disorders.
Mixed episodes may also occur during the course of bipolar I disorder and are
marked by symptoms of depressed and manic episodes co-occurring within a one-week
period (APA, 1994). Research on the neurocognitive deficits associated with mixed
episodes is extremely limited.
A diagnosis of bipolar I disorder is made once a manic or mixed episode has
occurred. Bipolar II disorder, on the other hand, is diagnosed when a depressive episode
and a hypomanic episode have occurred. Thus, bipolar II disorder is characterized by
oscillations between depressive episodes and hypomanic episodes, which are similar to
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manic episodes but are characterized by attenuated symptoms that are shorter in duration,
do not include symptoms of psychosis, do not cause significant social or occupational
distress, and do not require hospitalization. Similar to bipolar I disorder, bipolar II
disorder is also generally accompanied by interepisode periods of euthymia. One of the
primary differences between the subtypes of bipolar disorder is that individuals with
bipolar II disorder seem to demonstrate less severe neuropsychological impairments than
do individuals with bipolar I disorder, although findings are inconclusive in this regard
(Dittmann et al., 2008; Simonsen et al., 2008).
Neurocognitive Deficits Associated with Bipolar Disorder
In addition to the mood symptoms required to warrant a diagnosis of bipolar
disorder, research has indicated that neurocognitive deficits often accompany the disorder
irrespective of the subtype (e.g., Dickerson et al., 2004), with some deficits present as
early as the first hospitalization (Gruber, Rosso, & Yurgelun-Todd, 2008). The presence
of neurocognitive deficits in individuals with BP has led many researchers to hypothesize
that structural brain deficits are present in such individuals which reflect the noted
neurocognitive deficits.
The right hemisphere of the brain has historically been associated with BP, with
the earliest such hypotheses being formulated by Flor-Henry (1976; 1983), who
hypothesized the presence of right hemispheric dysfunction in such individuals after
noticing a verbal-performance IQ split. It thus follows that deficits in the neurocognitive
domains of visuospatial processing and memory have traditionally been considered to be
characteristic of bipolar disorder (Flor-Henry, 1976, 1983). Subsequent studies have
yielded mixed results, with some research being reported which has found support of
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right hemispheric dysfunction in affective disorders (e.g., Wexler, 1980; Taylor, Redfield,
& Abrams, 1981), and other research being reported which has not found evidence in
support of this hypothesis (e.g., Calev, Korin, Shapira, Kugelmass, & Lerer, 1986;
Newman & Silverstein, 1987). More recent research specifically investigating the right
hemisphere hypothesis via the evaluation of performance of individuals with BP on
visuospatial memory tasks has also yielded mixed results (Bearden, Hoffman, & Cannon,
2001).
Many studies of neurocognitive deficits in BP have grouped together individuals
in depressive, manic and mixed episodes with patients who were euthymic, sometimes
making little or no distinction between the episodes when evaluating neuropsychological
functioning. These studies have identified neurocognitive deficits in the neurocognitive
domains of executive functioning (Fleck, Shear, Madore, & Strakowski, 2008; Gruber et
al., 2008; Simonsen et al., 2008), memory (Gruzelier, Seymour, Wilson, Jolley, & Hirsch,
1988), nonverbal learning and memory (Gruzelier et al., 1988), verbal learning and
memory (Henry, Weingartner, & Murphy, 1973), and attention (Simonsen et al., 2008).
Manic episodes. Multiple studies have also investigated the neurocognitive
deficits associated with specific mood episodes. Individuals in a current manic episode,
for example, have been found to suffer from impairments in the area of verbal learning
and memory, which has, in fact, also been found to be significantly more impaired during
manic episodes than during periods of nonmania (Henry, Weingartner, & Murphy, 1971).
Furthermore, BP individuals in a current manic episode have been found to
demonstrate more widespread and severe cognitive impairments as compared to those in
either a current major depressive episode or euthymic state, especially in the areas of

18

executive functioning (Dixon, Kravariti, Frith, Murray, & McGuire, 2004), working
memory, and problem solving skills (Sweeney, Kmiec, & Kupfer, 2000).
Major depressive episodes. The neurocognitive deficits that often accompany
major depressive episodes have been examined in individuals suffering from unipolar
depression and include verbal learning and memory impairments, possibly due to a
deficit in the ability to encode information in an organized fashion – a deficit which
resembles impairments commonly observed in individuals with Alzheimer’s disease
(Weingartner, Cohen, Murphy, Martello, & Gerdt, 1981).
Periods of euthymia. Researchers have also investigated neurocognitive deficits
during periods of euthymia, with the idea that these deficits may be trait markers of BP
and not associated specifically with periods of affective dysregulation. Support for the
hypothesis that there are such persisting neurocognitive deficits has been somewhat
inconsistent (Fleck, Shear, Madore, & Strakowski, 2008). Nevertheless, the
identification of stable deficits during periods of euthymia may in turn help identify
vulnerability markers, thus potentially aiding in the development of screening tools for
vulnerability to BP. Studies evaluating individuals with BP have found deficits during
periods of euthymia, including in the neurocognitive domains of verbal learning and
memory (Atre-Vaidya et al., 1998; van Gorp, Altshuler, Theberge, Wilkins, & Dixon,
1998; van Gorp, Altshuler, Theberge, & Mintz, 1999; Altshuler et al., 2004; MartínezArán, Vieta, Colom et al., 2004; Thompson et al., 2005; Robinson et al., 2006; MartínezArán et al., 2007; Martino et al., 2008), attention (Dickerson et al., 2004; Martínez-Arán,
Vieta, Colom et al., 2004; Thompson et al., 2005; Arts, Jabben, Krabbendam, & van Os,
2008), nonverbal (i.e., visual) learning and memory (Glahn, Barrett et al., 2006; Arts et
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al., 2008), verbal fluency (Atre-Vaidya et al., 1998; de Almeida Rocca et al., 2008) oral
language (Dickerson et al., 2004), visual organization and reasoning (Atre-Vaidya et al.,
1998), visuospatial processing (El-Badri, Ashton, Moore, Marsh, & Ferrier, 2001) and
recognition memory for patterns and spatial locations (Rubinsztein et al., 2000;
Thompson et al., 2005), immediate and delayed memory (Dickerson et al., 2004),
psychomotor functioning (Thompson et al., 2005), spatial orientation (Atre-Vaidya et al.,
1998), mental processing speed (Arts et al., 2008), and executive functioning (van Gorp,
Altshuler, Theberge, Wilkins et al., 1998; Ferrier, Stanton, Kelly, & Scott, 1999;
Altshuler et al., 2004; Martínez-Arán, Vieta, Colom et al., 2004; Thompson et al., 2005;
Robinson et al., 2006; Martínez-Arán et al., 2007; Arts et al., 2008; Martino et al., 2008).
At least one study, however, found deficits in executive functioning to improve during
extended periods of euthymia, despite a continued impairment in visual memory during
such periods (Rubinsztein, Michael, Paykel, & Sahakian, 2000). Similarly, evidence of
neurocognitive deficits in the areas of visual and verbal memory have been found in a
group of generally euthymic BP individuals (Frantom, Allen, & Cross, 2008; Savitz, van
der Merwe, Stein, Solms, & Ramesar, 2008).
Neuroimaging studies have also identified structural and functional brain
abnormalities that underlie these neurocognitive deficits, with the structural abnormalities
observed in individuals with BP including lateral ventricular enlargement (Pearlson et al.,
1984) and, in a group of males diagnosed with BP, larger caudate volumes (Aylward et
al., 1994). For a review of such studies and for more in-depth information regarding
structural abnormalities in individuals with BP, see Bearden, Hoffman, and Cannon
(2001).
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Verbal and Visual Learning and Memory in Bipolar Disorder
As previously mentioned, verbal learning and memory deficits have been studied
extensively in individuals with bipolar disorder. At least one study, in fact, reported
evidence of a specific genetic variation, specifically of the COMT gene on chromosome
22q11, that is both common in bipolar I disorder and associated with the verbal memory
deficits observed in individuals with BP (Burdick et al., 2007). Furthermore, reduced
frontal, posterior temporal, cingulate and occipital cerebral blood flow (CBF) has been
noted in individuals with BP who also demonstrated impaired verbal learning and
memory (Benabarre et al., 2005). Not only have such deficits been repeatedly reported,
but some studies have found that verbal learning and memory is affected to a greater
degree than other neurocognitive areas in individuals with BP. Martínez-Arán, Vieta,
Reinares and colleagues (2004), for example, examined 108 individuals with BP, who
were either currently in a major depressive episode (n = 30), in a manic or hypomanic
episode (n = 34), or euthymic (n = 44), as well as normal control participants (n = 30).
Results indicated that, overall, individuals with BP were significantly impaired as
compared to the normal control participants, especially in the areas of executive
functioning and verbal learning and memory, though they were also found to be impaired
in the areas of attention, verbal fluency, and nonverbal learning and memory. There were
also significant differences within the BP group in verbal learning and memory as
measured by the California Verbal Learning Test. Specifically, while all BP individuals
demonstrated significant impairments in relation to normal controls in short- and longdelay free recall and long delay cued recall. However, only those who were in a current
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episode were found to be significantly impaired in the area of recognition as compared to
normal controls; those who were euthymic performed similarly to normal controls.
A similar study, performed by Basso, Lowery, Neel, Purdie, and Bornstein (2002),
compared a group of normal controls (n = 31) to individuals with BP who were either in a
major depressive episode (n = 25), a manic episode (n = 37), or a mixed episode (n = 24)
at time of testing. Results indicated that the bipolar group as a whole was significantly
impaired compared to the normal control group in the domains of verbal learning and
memory, executive functioning, speed of information processing, and fine motor skills.
When the BP group was compared according to type of mood episode, however, no
differences in degree of impairment were noted, thus suggesting that the
neuropsychological profile demonstrated by individuals suffering from a mood episode is
similar regardless of the type of episode (Basso et al., 2002).
Bearden and colleagues (2006) further explored the presence and nature of verbal
learning and memory impairments in a group of individuals with BP (n = 49; 8% were
currently euthymic, 29% were in a major depressive episode, and 33% were in a mixed,
hypomanic or manic episode; the remaining 30% had mild to moderate symptomatology
at time of testing) as compared to a group of matched normal controls (n = 38). The BP
group was found to demonstrate significant verbal learning and memory impairment in
relation to the normal controls with no significant differences in performance within the
BP group according to type of current episode. Additionally, the nature of these
impairments and the specific errors made suggested an encoding deficit in the group as
evidenced by the fact that, while there was no significant difference between the two
groups in number of words learned on trials 1 and 2 of the CVLT, the BP group was able
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to recall significantly fewer words on trials 3 through 5 as compared to the normal
controls, with the discrepancy growing more evident with each subsequent trial.
Furthermore, the BP group’s performance was significantly below that of the normal
controls in number of words recalled on short- and long-delay free and cued recall.
Nevertheless, the BP group forgot no more words than did the control group between the
short- and long-delay tasks, thus again suggesting that the deficit was one of encoding.
Another study reported very similar findings, but with a group of individuals with BP
who were all currently euthymic at time of testing (n = 30; Deckersbach et al., 2004).
Evidence of visual learning and memory impairments have also been reported to
be present in individuals suffering from BP, although findings have yielded mixed results.
Martínez-Arán, Vieta, Reinares and colleagues (2004), for example, found evidence of
visual memory impairment in a group of individuals with BP (n = 108; approximately
27.8% of whom were depressed, 31.5% manic or hypomanic, and 40.7% euthymic at
time of testing) as compared to a group of normal controls (n = 30). The presence of
such impairments, however, was found to be dependent on mood state and on severity.
Specifically, only those who were acutely ill demonstrated impairments in visual delayed
recall, and only those who were currently in a major depressive episode were impaired in
demonstrated visual immediate recall. Furthermore, Altshuler and colleagues (2004)
found a group of males diagnosed with BP (n = 40), all of whom were euthymic at time
of testing, to perform worse than a group of normal controls (n = 22) in the
neurocognitive domains of verbal memory and executive functioning. Furthermore, the
BP group performed similarly to a group of males diagnosed with schizophrenia (n = 20)
in the domain of verbal learning and memory, and significantly better than the
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schizophrenia group in executive functioning. A subgroup of the BP participants,
however, exhibited no impairments in executive function, suggesting that some
individuals with BP may have spared executive function.
Furthermore, research has demonstrated a relationship between visual learning
and memory deficits and the co-occurring presence of a genetic vulnerability to BP.
Specifically, Frantom, Allen, and Cross (2008) found that healthy first-degree relatives of
individuals with BP (n = 19) were significantly impaired in the domain of visual learning
and memory as compared to a normal control group (n = 19). Such a finding suggests
that, similar to impairments in verbal learning and memory, visual learning and memory
deficits may be trait markers for the presence of BP.
Psychotic/Affective Disorders: Bipolar Disorder with Psychosis
Characteristics of Bipolar Disorder with Psychosis
In addition to mood symptoms, BP is sometimes accompanied by psychotic
features in the form of delusions and/or hallucinations (APA, 1994), with one large-scale
study reported a history of psychosis in 61% of a group of patients who had been
hospitalized for either an affective disorder or schizoaffective disorder (Angst, Sellaro,
Stassen, & Gamma, 2005). Psychosis within BP has been associated with a more severe
course of illness (APA, 1994; Zubieta, Huguelet, O’Neil, & Giordani, 2001), especially
in terms of more residual symptoms, an extensive course with little or no interepisode
remission, and the presence of rapid cycling (Bora et al., 2007). BP with psychotic
features has also been found to be associated with more impaired functional outcome
when compared with individuals with BP without psychotic features (APA, 1994;
Zubieta et al., 2001).
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Once an individual has experienced a mood episode accompanied by psychotic
features, he/she is more likely to have more such psychotic affective episodes.
Additionally, the presence of psychosis within a manic episode is associated with a
greater likelihood of future manic episodes with psychotic features, while the presence of
mood-incongruent psychotic features is associated with a decreased likelihood of full
interepisode recovery (APA, 1994), as well as greater social maladjustment and more
severe symptoms over a 9-month post-hospitalization period (Miklowitz, 1992). In fact,
while Tohen and colleagues (2000) found that 97.5% of a group of individuals suffering
from a major affective disorder (i.e., either BP or major depressive disorder) with
psychotic features demonstrated syndromal recovery within 2 years following first
hospitalization, only 37.6% were found to demonstrate functional recovery (as measured
via a return to at least baseline levels in both vocational status and living situation) during
the same time period, with older age at onset and shorter hospitalization duration were
both found to be associated with a greater likelihood of significant functional recovery.
Neurocognitive Deficits Associated with Bipolar Disorder with Psychosis
Recently, a number of investigations have found evidence of differences in
neurocognitive performance to be associated with the presence or absence of psychotic
symptoms in BP, with deficits having found to be significantly more severe when BP is
accompanied by psychotic features (APA, 1994; Zubieta, Huguelet, O’Neil, & Giordani,
2001).
Zubieta, Huguelet, O’Neil, and Giordani (2001), for example, evaluated the
neuropsychological performance of a group of individuals with BP with psychosis (n =
15), each of whom had been euthymic for at least 6 months, as compared to a group of
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normal controls (n = 15). The BP with psychotic features group was found to be
significantly impaired in verbal learning, executive functioning, and motor coordination.
No BP without psychosis group was included for comparison. Additionally, a greater
number of mood episodes (both depressive and manic) was associated with more severe
impairment of executive functioning in the BP with psychosis group, while greater
impairments in both executive functioning and verbal learning and memory were found
to be associated with greater impairments in social and occupational functioning. These
results suggest that at least some of the neurocognitive deficits associated with BP with
psychosis may indicate the presence of a more severe course and greater impairments in
functional outcome.
Moreover, Bora and colleagues (2007) compared a group of euthymic BP patients
(n = 65) to a group of normal controls (n = 30) in several neurocognitive domains. Of the
BP group, approximately 62% had experienced at least one mood episode which was
accompanied by psychotic features. The BP group as a whole performed significantly
worse than the normal controls in the areas of attention and psychomotor speed, as well
as on some measures of verbal fluency. The psychotic BP subgroup further exhibited
significant impairment in the areas of executive functioning as compared to both the
normal controls and the individuals with BP without psychotic features.
In a similar study, Glahn and colleagues (2007) compared the neuropsychological
profiles of individuals with BP with (n = 34) and without (n = 35) psychotic features to
one another, as well as to a group of normal controls (n = 35). The makeup of the BP
group was a combination of individuals in major depressive and manic episodes, as well
as individuals who were currently euthymic. Compared to the normal controls, the BP

26

group as a whole performed significantly worse in the areas of attention, psychomotor
speed, episodic memory, and executive functioning. Moreover, the BP with psychotic
features group was significantly more impaired than the BP without psychotic features
group in the areas of executive functioning and spatial working memory, further lending
support to the hypothesis that psychosis may indicate more severe impairment. Greater
severity in neuropsychological impairment was also found by Evans and colleagues
(1999) to be associated with psychiatric disorders with psychosis as compared to those
without psychotic features, specifically in the neurocognitive domains of psychomotor
speed, abstract thinking, attention, and verbal learning and memory.
Another trend in BP research has been to investigate whether documented
impairments are present very early on in the course of the disorder, which could lead to
the identification of impairments that may be markers for the presence of the disorder,
and perhaps for the presence of psychotic features within the disorder. Brickman and
colleagues (2004), for example, examined the neuropsychological performance of a
group of adolescents (n = 29) who were experiencing a psychotic episode for the first
time and who thus had not been previously medicated for psychosis, and who were later
diagnosed with schizophrenia. The psychotic group was found to be significantly
impaired when compared to a group of age- and gender-matched control subjects (n = 17),
especially in the areas of executive functioning, attention, and verbal learning and
memory, and to a lesser degree in the areas of verbal fluency, perceptual motor
processing, and motor speed.
Recently, Allen, Randall, Bello, Armstrong, Frantom, and Kinney (in press)
evaluated working memory performance in individuals with BP with (n = 24) and
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without (n = 22) and psychotic features, as well as a group of normal controls (n = 31).
Working memory was conceptualized according to the model proposed by Baddeley and
Hitch (Baddeley & Hitch, 1974), which includes three main components – the
Phonological Loop, the Visuospatial Sketchpad, and the Central Executive. It was
hypothesized that the BP group with psychotic features would perform significantly
worse than the nonpsychotic BP and normal control groups on neurocognitive measures
selected to assess these three working memory components. However, results indicated
that only the Central Executive component significantly differentiated the psychotic and
nonpsychotic BP groups (see Figure 1). These results support the idea that some aspects
of working memory performance are trait markers for psychosis while others are not, and
implicate the role of executive function deficits as key in predicting poorer working
memory performance in patients with BP who also have experienced psychotic episodes.
Finally, Glahn et al. (2006) reported that performance on spatial working memory
tasks differentiated between patients with histories of psychosis (BP with psychosis,
schizoaffective disorder, and schizophrenia) from those without psychotic features (BP
without psychosis), although differences were not present between these groups on
auditory/verbal working memory tasks. It is interesting to note that the spatial working
memory task used likely placed heavy demands on the Central Executive in addition to
the Visuospatial Sketchpad. The results obtained thus may not be specific to the visual
short-term store per se, but may have instead resulted from executive function deficits. In
any case, there is a growing consensus that deficits in working memory, and potentially,
executive function are markers for psychosis rather than for affective disorders.
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Figure 1. Phonological Loop, Visuospatial Sketchpad, Central Executive, and Composite
Scores for the Groups.1
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From “Are working memory deficits in bipolar disorder markers for psychosis?” by D.

N. Allen, C. Randall, D. K. Bello, C. M. Armstrong, L. V. Frantom, and J. W. Kinney,
2010, Neuropsychology, in press. Adapted with permission of the author.
Note. NC = Normal control group. BP- = Bipolar disorder without psychotic features
group. BP+ = Bipolar disorder with psychotic features group. C1 = California Verbal
Learning Test List A, Trial 1. CB = California Verbal Learning Test List B. DS = Digit
Span Total. B1 = Biber Figure Learning Test-Extended Trial 1. BD = Biber Figure
Learning Test-Extended Distractor List. SS = Spatial Span Total. TA = Trail Making Test
Part A. TB = Trail Making Test Part B. PE = Wisconsin Card Sorting Test Perseverative
Errors. FMS= Wisconsin Card Sorting Test Failure to Maintain Set. CAT = Wisconsin
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Card Sorting Test Categories Completed. PL = Phonological Loop Composite Score. VS
= Visuospatial Sketchpad Composite Score. CE = Central Executive Composite Score.

Verbal and Visual Learning and Memory in Bipolar Disorder with Psychosis
Research regarding the presence of verbal and visual learning and memory
deficits in individuals diagnosed with BP with psychotic features has been limited.
Additionally, much of the research that has considered the co-occurrence of BP and
psychotic features has not controlled well for the presence of absence of psychosis, which
may be one of the reasons why mixed results have been reported in the BP research to
date. As previously mentioned, Zubieta, Huguelet, O’Neil, and Giordani (2001)
compared a group of individuals with BP with psychotic features (n = 15) to a group of
normal controls (n = 15). Although a BP without psychosis group was not also used as a
comparison, the BP with psychosis group did exhibit significant verbal learning and
memory impairments, as well as impairments in executive functioning.
Brickman and colleagues (2004) also found evidence of significant deficits in the
domains of executive functioning and verbal learning and memory in a group of
previously unmedicated adolescents presenting with psychotic symptoms (n = 29) who
went on to be diagnosed with schizophrenia as compared to a group of matched control
subjects (n = 17).
McClellan, Prezbindowski, Breiger, and McCurry (2002) similarly compared a
group of medication-naïve adolescents who had been diagnosed with BP with psychotic
features (n = 14), schizophrenia (n = 18), schizoaffective disorder (n = 7), or psychosis
not otherwise specified (n = 11) on various neurocognitive domains and found evidence
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of impaired verbal learning and memory in all three groups. No significant difference,
however, was noted between the three groups with regard to verbal learning and memory,
suggesting that such a deficit may be a marker for psychosis.
Bora and colleagues (2007) also compared a group of individuals with BP with a
history of psychotic features (n = 40) to a group of normal controls (n = 30) across
several neurocognitive domains. Overall, the BP with psychosis group was found to be
significantly impaired in the areas of attention, psychomotor speed, executive functioning,
and some measures of verbal fluency. Furthermore, the executive function deficits which
were noted in the BP with psychosis group were also significant as compared to a group
of individuals with BP without a history of psychosis (n = 25), whose executive
functioning overall was indistinguishable from that of normal controls. Executive
functioning, and not verbal learning and memory thus differentiated between the presence
and absence of psychosis in this sample.
Finally, neuropsychological findings from high-risk studies, retrospective studies,
and birth cohort studies have demonstrated evidence of visuospatial memory deficits that
existed prior to the onset of psychosis. Investigators in this review assert from these
findings that visuospatial memory deficits may be viewed as trait markers for psychotic
illness (Brewer et al., 2006).
However, despite evidence implicating visuospatial memory deficits, specific
studies regarding whether visual learning and memory may be differentially impaired in
individuals with BP with versus without psychotic features have yet to be conducted.
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Psychotic/Affective Disorders: Schizoaffective Disorder
Characteristics of Schizoaffective Disorder
Schizoaffective disorder is a psychiatric disorder which is listed in the DSM-IVTR in the “Schizophrenia and Other Psychotic Disorders” section, but which is expressed
as a combination of the symptoms typically associated with schizophrenia and bipolar
disorder (APA, 1994). Symptoms required to warrant a diagnosis of schizoaffective
disorder include the presence of two or more of the characteristic symptoms of
schizophrenia (i.e., delusions, hallucinations, disorganized speech, disorganized and/or
catatonic behavior, and negative symptoms). The primary factor which distinguishes
schizoaffective disorder from schizophrenia is the diagnostic criterion of at least one
major depressive, manic, or mixed episode which occurs concurrently with the previously
mentioned schizophrenia symptoms, while the primary factor which distinguishes
schizoaffective disorder from BP is that the presence of delusions and/or hallucinations
must be documented in the absence of prominent mood symptoms for at least a 2 week
period. Research regarding the prevalence of schizoaffective disorder has been extremely
limited (APA, 1994), with the only such study reporting a prevalence estimate of
approximately 0.32% (Perala et al., 2007).
Neurocognitive Deficits Associated with Schizoaffective Disorder
Research regarding the neurocognitive deficits associated with schizoaffective
disorder is limited, although there have been some reports of documented impairment in
the neurocognitive domains of verbal memory, attention, and executive functioning
(Torrent et al., 2007), as well as working memory (Gooding & Tallent, 2002).
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Some studies have also compared the neuropsychological profiles of individuals
with schizoaffective disorder as compared to individuals with schizophrenia. One such
study, performed by Heinrichs, Ammari, Vaz, and Miles (2008), found the
neurocognitive profiles of groups of individuals with schizophrenia (n = 103) and
schizoaffective disorder (n = 48) to be statistically indistinguishable from one another,
specifically in the neurocognitive domains of verbal learning and memory, processing
speed, nonverbal reasoning, verbal fluency, and verbal skills. This similarity in
performance was present despite the finding that the schizophrenia group was
significantly more symptomatic than the schizoaffective group at time of testing.
Similarly, Szoke and colleagues (2008) compared groups of individuals with
schizophrenia (n = 48), schizoaffective disorder (n = 26), bipolar disorder with psychosis
(n = 52), and bipolar disorder without psychosis (n = 40), as well as a group of normal
controls (n = 48) on two measures of executive functioning – the Wisconsin Card Sorting
Test (WCST) and the Trail Making Test (TMT). Results indicated that all four
psychiatric groups performed worse than normal controls on the TMT, although this
difference was significant only for the schizophrenia and schizoaffective groups.
Furthermore, degree of impairment of executive function as measured by the TMT was
similar in the schizophrenia and schizoaffective disorder groups, and in turn for the two
bipolar disorder groups. On the other hand, degree of impairment of executive function
as measured by the WCST was most severe in the schizophrenia group, followed by the
schizoaffective disorder, bipolar disorder with psychosis, and bipolar disorder without
psychosis groups respectively. Only the WCST performance of the schizophrenia and

33

schizoaffective disorder groups, however, was significantly worse than that of the normal
control group.
Verbal and Visual Learning and Memory in Schizoaffective Disorder
As with neurocognitive impairments in general, research regarding verbal and
visual learning and memory in schizoaffective disorder is extremely limited. One study,
however, performed by Torrent and colleagues (2007) compared a group of individuals
with schizoaffective disorder (n = 34) to a group of individuals with bipolar disorder
without psychosis (n = 41), as well as a group of normal controls (n = 35). All
psychiatric participants were euthymic at time of testing. Results indicated that the
schizoaffective group demonstrated more severe impairments in the neurocognitive
domains of executive functioning, attention, and verbal memory as compared to both the
bipolar disorder and normal control groups, with the bipolar disorder group performing
similar to the normal control group.
Little research has been reported to date regarding the presence or absence of
visual learning and memory deficits in individuals with schizoaffective disorder. The
previously mentioned study conducted by Torrent and colleagues (2007), however, was
unable to identify visual learning and memory deficits in a group of individuals with
schizoaffective disorder as compared to a group of individuals with BP and a group of
normal controls.
Schizophrenia
Characteristics of Schizophrenia
Schizophrenia is a typically debilitating psychiatric disorder which is
characterized by a mixture of both positive and negative symptoms (APA, 1994).
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Positive symptoms include delusions and hallucinations, disorganized speech, and
disorganized or catatonic behavior, while negative symptoms include affective flattening,
alogia, and avolition. Symptoms must have been present for at least a 1-month period of
time (or shorter if treated), with at least some of the symptoms having been present for at
least 6 months to warrant a diagnosis. Furthermore, symptoms must be causing or must
have caused significant impairment in social and/or occupational functioning. Estimates
of the prevalence of schizophrenia vary and typically range from approximately 0.5% to
1.5% (APA, 1994; Waldo, 1999; Chien et al., 2004; Xiang et al., 2008).
As with BP, much heterogeneity exists in the expression of schizophrenia. The
DSM-IV delineates five subtypes of schizophrenia – paranoid, disorganized, catatonic,
undifferentiated, and residual. Within and among these subtypes, neuropsychological
performance may vary from significantly impaired to “neuropsychologically normal”
(Palmer et al., 1997; Kremen, Seidman, Faraone, Toomey, & Tsuang, 2000; Seaton,
Goldstein, & Allen, 2001; Allen, Goldstein, & Warnick, 2003).
Also as with BP, attempts have been made to link the neurocognitive deficits
commonly associated with schizophrenia to structural abnormalities of the brain. One
such study found evidence, albeit from a relatively small sample of individuals with
schizophrenia (n = 12), of impaired left hemisphere activation and apparent impaired
phonological processing during verbal tasks as compared to a small group of normal
controls (n = 12; Angrilli et al., 2009). Other studies have reported evidence for left
temporal lobe dysfunction, where there may be a relationship between dysfunction and
the presence of auditory hallucinations (e.g., Hugdahl et al., 2008). Furthermore, the
presence of schizophrenia may be associated with decreased gray matter volume in areas
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of the frontal and medial temporal lobes, especially those of the left hemisphere (Bonilha
et al., 2008). For a review of early left hemisphere dysfunction research, see Maaser and
Farley (1988).
Neurocognitive Deficits Associated with First-Break Findings
As with BP, attempts have been made to identify what, if any, neurocognitive
impairments are present early in the course of schizophrenia. Lencz and colleagues
(2006), for example, administered a battery of tests to a group of individuals who were
determined to be susceptible to the onset of psychotic symptoms based on the presence of
other positive symptoms. As compared to a group of normal controls, the vulnerable
group demonstrated significant deficits in the areas of verbal learning and memory and
executive functioning. Of the individuals in the vulnerable group, those who later went
on to receive psychotic diagnoses (39%) had performed significantly worse in the area of
verbal learning and memory than did those who did not go on to develop such disorders.
Furthermore, Albus, Hubmann, Ehrenberg and colleagues (1996) compared a
group of individuals suffering from first-episode schizophrenia (n = 40) to a group of
individuals with chronic schizophrenia (n = 40), as well as to a group of normal controls
(n = 40). The schizophrenia groups demonstrated significant generalized cognitive
impairment as compared to the normal controls, specifically in the areas of verbal
intelligence, verbal learning and memory, spatial organization, visual memory, short-term
memory, visual-motor processing selective attention, information processing, and
abstraction, suggesting that the neurocognitive impairments commonly associated with
schizophrenia may be present very early on in its course, and may thus potentially serve
as prodromal markers for the onset of the disorder.
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As previously mentioned, Albus, Hubmann, Walheim, and colleagues (1996) also
compared the neuropsychological performance of several groups of psychiatric patients
to one another and to a group of normal controls. One of these groups was a
schizophrenia group, which was comprised of individuals who were experiencing their
initial psychotic episode. Among other findings, the researchers found that the first
episode schizophrenia group (n = 27) performed significantly worse than the normal
control group (n = 27) in the area of verbal learning and memory.
Similarly, Saykin, and colleagues (1994) compared the neurocognitive
performance of a group of individuals with first-episode, and thus never medicated,
schizophrenia (n = 37), a group with schizophrenia who had been previously treated with
medication (n = 65), and a group of normal controls (n = 131). The pattern of
performance of the two patient groups was remarkably similar in the areas of sustained
attention, verbal intelligence, spatial organization, visual memory (i.e., spatial
recognition), speed of visual-motor processing, fine motor skills, and verbal learning and
memory. While there were differences in performance between the two patient groups,
both patient groups were significantly impaired compared to the normal controls in each
of the domains. These results thus provide evidence that while these cognitive
impairments may be more extreme following extensive course and/or medication use,
they are, at least in some cases, present at the onset of the disorder and prior to treatment
via medication.
Bilder and colleagues (2000) also compared the neuropsychological profiles of a
group of individuals suffering from first-episode schizophrenia (n = 94), all of whom
were tested only following stabilization of psychosis, to a group of normal control
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participants (n = 36). Overall, the schizophrenia group demonstrated general cognitive
impairments compared to the normal controls, with deficits lying specifically in the areas
of learning and memory and executive functioning. Lower scores on measures of
executive functioning were also found to be associated with more severe cognitive
impairments in the psychiatric group. Furthermore, there was a significant relationship
between more severe cognitive impairment and more severe impairments in premorbid
adjustment, as well as between executive functioning deficits and both more severe
outcome and greater global functioning impairment.
Another study, performed by Townsend, Malla, and Norman (2001), examined
the neuropsychological functioning of a group of individuals, each suffering from firstepisode psychosis with a diagnosis of a schizophrenia spectrum psychosis disorder (i.e.,
schizophrenia, schizoaffective disorder, or schizophreniform disorder); each participant
was tested following stabilization of psychotic symptoms within the previous three
months. No normal control group was used for comparison in this study. Instead, zscores were calculated for each participant based on the normative values for the
measures. Results indicated that each of the three groups performed in the impaired
range in the domains of speed of information processing and executive functioning,
although there was no significant difference in performance between the three diagnostic
groups. These findings are thus concordant with other findings that neuropsychological
deficits associated with psychosis may be evident early in the course of psychotic
disorders.
Other deficits which have been noted as early as the first episode in individuals
with schizophrenia have included visual sensory processing (Yeap, Kelly, Thakore, &
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Foxe, 2008), attention (González-Blanch et al., 2007; Braw et al., 2008), spatial memory
(Braw et al., 2008), sequence learning (Pedersen et al., 2008), executive functioning
(Ilonen et al., 2000; Riley et al., 2000; Chan, Chen, & Law, 2006; González-Blanch et al.,
2007), fine motor skills (González-Blanch et al., 2007), psychomotor speed (Riley et al.,
2000), verbal fluency (Riley et al., 2000), nonverbal delayed memory (Riley et al., 2000),
and working memory (Gooding & Tallent, 2002; Mathes et al., 2005). Furthermore, at
least some of these findings were found to be significant regardless of whether the
participants were being treated via medication for the presence of psychotic features (e.g.,
Riley et al., 2000). Studies evaluating verbal and learning and memory performance in
first-episode schizophrenia patients, however, have yielded mixed results (Riley et al.,
2000; Hill, Beers, Kmiec, Keshavan, & Sweeney, 2004; Nuyen, Sitskoorn, Cahn, & Kahn,
2005).
The structural abnormalities often associated with schizophrenia have also been
noted as early as first-break in several groups of individuals. Such findings have
included significantly less grey matter in the dorsolateral prefrontal and superior temporal
gyrus in a group of individuals who were experiencing a psychotic episode and who were
later diagnosed as having schizophrenia (n = 37) as compared to a group of normal
controls (n = 44; Molina et al., 2006), as well as white matter abnormalities in a group of
first-episode schizophrenia participants (n = 25) as compared to a group of normal
controls (n = 26; Whitford et al., 2007). For an in-depth review of such findings, see
Steen, Mull, McClure, Hamer, and Lieberman (2006).
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Verbal and Visual Learning and Memory in Schizophrenia
As previously mentioned, findings have been mixed regarding the presence of
verbal learning and memory deficits in first break schizophrenia. The presence of such
deficits has, however, been repeatedly noted throughout the course of the disorder (Vaz
& Heinrichs, 2002; Tuulio-Henriksson, Partonen, Suvisaari, Haukka, & Lönnqvist, 2004).
In fact, verbal learning and memory impairments have been found to be associated with
earlier age at onset in these populations (Tuulio-Henriksson et al., 2004), while verbal
memory errors have been found to significantly predict general psychopathology as
measured by the Brief Psychiatric Rating Scale (BPRS; Overall & Gorham, 1962) in
individuals with schizophrenia (Heinrichs & Vaz, 2004). Interestingly, however,
subgroups of schizophrenia have been delineated according to performance on verbal
learning and memory tasks. Specifically, research has shown that there is a
subpopulation of individuals with schizophrenia whose performance on verbal learning
and memory tasks is comparable to that of normal controls, while other individuals
demonstrate significant impairment (Paulsen et al., 1995; Turetsky et al., 2002; Vaz &
Heinrichs, 2002, 2006). Relatively unimpaired performance on these tasks has been
further found to be associated with the presence of fewer symptoms, both negative and
positive (Turetsky et al., 2002; Vaz & Heinrichs, 2002, 2006), as well as better quality of
life as quantified by amount of sleep and rest typically obtained as well as contact with
family and friends. Some researchers, however, posit that such differences may have
been in part due to differences in medication use (Vaz & Heinrichs, 2002, 2006).
Multiple studies have also documented the presence of visual learning and
memory impairments in individuals with schizophrenia (e.g., Saykin et al., 1994). One
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such study, for example, found visual learning and memory to be significantly impaired
in a group of individuals with schizophrenia (n = 41) as compared to a group of normal
controls (n = 46; Nestor et al., 2004), while another study found visual learning and
memory as measured by the Biber Figure Learning Test-Extended (BFLT-E; Glosser,
Deutsch, Cole, & Corwin, 1997) to become increasingly more impaired over time as age
increased in a schizophrenia sample (Putnam & Harvey, 1999).
Finally, Tracy and colleagues (2001) specifically examined verbal and visual
learning and memory in a group of individuals with schizophrenia (N = 28) using the
CVLT to measure verbal learning and memory and the Biber Figure Learning TestExtended (BFLT-E) to measure visual learning and memory. Interestingly, the results
indicated that the group was significantly impaired on both the verbal and visual learning
and memory measures, but that visual learning and memory was, overall, more impaired
than verbal learning and memory.
Significance of Research
Neurocognitive Deficits and Outcome
One reason that the neurocognitive deficits associated with disorders such as BP
have been a major focus of recent research is that neuropsychological performance may
be more temporally stable than symptom presentation, and may also help to predict
outcome and severity of course (e.g., Liu et al., 2002; Lewis, 2004). Individuals with BP,
for example, tend to demonstrate impaired psychosocial and occupational functioning in
addition to neurocognitive deficits. Martínez-Arán and colleagues (2007) compared a
group of individuals with BP who had been euthymic for at least 6 months (n = 77) to a
group of normal controls (n = 35) and found that, overall, the BP group demonstrated
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more severe cognitive impairment compared to the normal controls, specifically in the
areas of verbal memory and executive functioning. The BP group was further divided
into two subgroups: a high-functioning group, described as having “a [Global
Assessment of Functioning (GAF)] score higher or equal to 60, [representing] some mild
difficulty in social, occupational or academic activities or satisfactory activity,…[but] in
general, the patient works quite well and has significant interpersonal relationships”; and,
a low-functioning group, described as having “[GAF] scores below 60, [indicating]
moderate to severe impairment in functioning”. Upon examining differences between
these two groups, the low-functioning BP group was found to be more severely impaired
than the high-functioning BP group, especially in the areas of executive functioning and
verbal memory. In fact, verbal memory was the best predictor of low psychosocial
functioning.
Earlier studies performed by Martínez-Arán and colleagues also investigated the
relationship between neuropsychological performance and psychosocial outcome. One
study demonstrated a significant positive correlation between performance on verbal
learning and memory tasks and psychosocial functioning as measured via the GAF
(Martínez-Arán, Vieta, Reinares et al., 2004). Furthermore, significant negative
correlations were found between performance on verbal learning and memory tasks and
duration of illness, number of hospitalizations, number of manic episodes, and number of
suicide attempts (Martínez-Arán, Vieta, Reinares et al., 2004). Another study performed
by Martínez-Arán, Vieta, Colom and colleagues (2004) found evidence of the following:
significant negative correlations between performance on verbal learning and memory
tasks and number of manic episodes, number of hospitalizations, and chronicity; a
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significant negative correlation between working memory and psychosocial functioning;
a significant positive correlation between performance on verbal learning and memory
tasks and psychosocial functioning; a significant negative correlation between
performance on tasks of executive functioning and duration of illness; and, a significant
positive correlation between performance on tasks of executive functioning and age of
onset. Overall, these studies provide further evidence that neurocognitive deficits,
especially in verbal learning and memory and executive functioning, are related to
psychosocial functioning and outcome (Martínez-Arán, Vieta, Colom et al., 2004;
Martínez-Arán, Vieta, Reinares et al., 2004).
Furthermore, given that episodes of mania are often associated with both
psychosis and hospitalization (Mansell & Pedley, 2008), further research regarding the
neuropsychological impairments, or lack thereof, which tend to accompany psychotic
features may lead to a better and more thorough understanding of BP with psychosis and
thus aid in treatment and intervention planning.
Genetic Markers for Psychosis
Finally, neuropsychological deficits may serve as trait markers for disorders,
which may indicate a genetic vulnerability to psychotic features. Gourovitch and
colleagues (1999), for example, compared the neuropsychological profiles of pairs of
monozygotic (MZ) twins who were discordant for BP (n = 7) to those of pairs of normal
control MZ twins (n = 7). Of the individuals in the discordant for BP group who had
been diagnosed with BP, three were euthymic, two were in a major depressive episode,
and two were in a manic episode at time of testing. Within the group of MZ twins
discordant for BP, the affected twins performed significantly worse than did the
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unaffected twins in the areas of attention (as measured via Digit Span Backward), facial
recognition, and verbal learning and memory (as measured via the CVLT). When the
two groups of twins were compared, the MZ twins discordant for BP were found to be
significantly impaired as compared to the normal control twins on the Brown-Peterson
test and in the domain of verbal learning and memory (as measured via the Wechsler
Memory Scale and the CVLT). The researchers concluded that mild deficits in overall
memory and/or retrieval may indicate a genetic vulnerability to BP. This study, however,
was implemented with a very small sample size, thus necessitating further research in this
area.
Conclusion
As has been demonstrated in the literature, multiple neurocognitive deficits are
associated with the presence of psychiatric disorders such as BP (both with and without
psychotic features), schizoaffective disorder, and schizophrenia. Recent research has
demonstrated the importance of considering the presence or absence of psychosis as an
important variable that is associated with unique patterns of cognitive deficits regardless
of diagnosis or diagnostic category. In this regard, working memory has received much
attention as a possible biobehavioral marker for psychosis, with preliminary results
indicating that visuospatial working memory and executive function deficits are sensitive
to psychosis in bipolar disorder and psychotic disorders. However, associations between
psychotic symptoms and other aspects of memory function, such as encoding, storage and
retrieval processes, have received much less attention. The research that has been
conducted has produced findings suggestive of verbal learning and memory deficits in all
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of these disorders, although findings have been mixed with regard to BP, with the role of
psychotic symptoms in memory deficits in these patients remaining unclear.
Research regarding the presence or absence of visual learning and memory
impairments in these disorders has been even less conclusive. There is however, some
suggestion that visual memory deficits are present in patients with BP, although the role
of psychotic symptoms in the expression of these memory deficits is not known. The
presence of neurocognitive deficits sensitive to psychosis rather than to a particular
diagnosis is consistent with recent research that has explored the idea that a spectrum of
disorders exists, and that BP, schizoaffective disorder and schizophrenia are not separate
disorders but are related on this spectrum. Given what appears to be the central role of
memory encoding, storage and retrieval processes to each of these disorders, it is thus
possible that a systematic careful examination of these processes may further
understanding regarding brain dysfunction in these disorders, assist in the identification
of endophenotypic markers that might distinguish between them, and clarify what up to
now are mixed results vis a vis the learning and memory literature in bipolar disorder.
See Table 1 for a visual representation of the findings to date regarding verbal and
nonverbal learning and memory, as well as executive function, in individuals with bipolar
disorder.
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Table 1. Summary of Research Findings to Date Regarding Executive Function and Verbal Learning and Memory Performance in
Bipolar Disorder.
Executive Function
State
Mood states not differentiated

•

Manic episode

•

Major depressive episode

•

Verbal and Nonverbal Memory

Studies lumping individuals from
varying mood states at time of
testing have found deficits in
executive function (e.g., Fleck,
Shear, Madore, & Strakowski, 2008;
Gruber et al., 2008; Simonsen et al.,
2008).
Studies evaluating individuals in
manic episodes at time of testing
have demonstrated not only that
impairments in executive function
are present during such states, but
that such deficits are more severe
than those noted in individuals who
were depressed or euthymic at time
of testing (e.g., Dixon, Kravariti,
Frith, Murray, & McGuire, 2004).
Individuals in depressed episodes at
time of testing have also
demonstrated deficits in executive
function, although such deficits
were noted to be modest in size
(e.g., Malhi et al., 2007).
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•

•

•

•

Studies lumping individuals from
varying mood states at time of
testing have found deficits in verbal
memory (e.g., Henry, Weingartner,
& Murphy, 1973).
Deficits in nonverbal memory have
also been reported in such samples
(e.g., Gruzelier et al., 1988).
Studies evaluating individuals in
manic episodes at time of testing
have demonstrated verbal learning
and memory impairments which
have been significantly more severe
than those observed during either
depressed or euthymic states (e.g.,
Henry, Weingartner, & Murphy,
1971; Dixon, Kravariti, Frith,
Murray, & McGuire, 2004).
Verbal learning and memory
impairments have been noted in
such samples, with deficits primarily
lying in the domain of encoding
(e.g., Weingartner, Cohen, Murphy,
Martello, & Gerdt, 1981).

Euthymia

•

Individuals who were euthymic at
time of testing have also
demonstrated deficits in executive
function (e.g., van Gorp, Altshuler,
Theberge, Wilkins et al., 1998;
Ferrier, Stanton, Kelly, & Scott,
1999; Altshuler et al., 2004;
Martínez-Arán, Vieta, Colom et al.,
2004; Thompson et al., 2005;
Robinson et al., 2006; MartínezArán et al., 2007; Arts et al., 2008;
Martino et al., 2008), although at
least one study found such deficits
to improve during euthymia
(Rubinsztein, Michael, Paykel, &
Sahakian, 2000).

•

•

BPI versus BPII

•

Research comparing individuals
with BPI and BPII have found
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•

Additionally, deficits in verbal recall
have been found to be most severe
in depressed individuals than in
individuals in other mood states
(e.g., Malhi et al., 2007).
Deficits in verbal learning and
memory have been reported in a
number of studies of individuals
with bipolar disorder who were
euthymic at time of testing (e.g.,
Atre-Vaidya et al., 1998; van Gorp,
Altshuler, Theberge, Wilkins, &
Dixon, 1998; van Gorp, Altshuler,
Theberge, & Mintz, 1999; Altshuler
et al., 2004; Martínez-Arán, Vieta,
Colom et al., 2004; Thompson et al.,
2005; Robinson et al., 2006;
Martínez-Arán et al., 2007;
Frantom, Allen, & Cross, 2008;
Martino et al., 2008; Savitz, van der
Merwe, Stein, Solms, & Ramesar,
2008).
Deficits in nonverbal learning and
memory have also been reported in
such samples (e.g., Glahn, Barrett et
al., 2006; Arts et al., 2008; Frantom,
Allen, & Cross, 2008; Savitz, van
der Merwe, Stein, Solms, &
Ramesar, 2008).
Some research regarding verbal
learning and memory has identified

evidence of impairment in executive
function in both groups as compared
to a normal control group, but with
no significant differences between
the BPI and BPII groups themselves
(e.g., Dittmann et al., 2008). Other
research, however, has reported
significant differences between
these groups, with the BPI group
performing significantly worse than
the BPII group, and with both
groups performing significantly
worse than a normal control group,
in the domain of executive function
(e.g., Torrent et al., 2006; Hsiao et
al., 2009).

BP+ versus BP-

•

such impairments in individuals
with BPI and BPII as compared to a
normal control group, with no
significant differences in the BPI
and BPII groups themselves, (e.g.,
Dittmann et al., 2008), while other
findings have included significant
differences between these two
groups, with the BPI group
performing significantly worse than
the BPII group, and with both
groups performing significantly
worse than a normal control group
(e.g., Torrent et al., 2006; Hsiao et
al., 2009).
Research to date has found no
evidence of differences between BPI
and BPII regarding nonverbal
learning and memory (e.g., Torrent
et al., 2006; Hsiao et al., 2009).
Verbal learning and memory
impairments have been reported in
BP+ individuals as compared to
normal controls (e.g., Zubieta,
Huguelet, O’Neil, & Giordani,
2001).

Deficits in executive function have
•
been noted in BP+ individuals as
compared to normal controls (e.g.,
Zubieta, Huguelet, O’Neil, &
Giordani, 2001), and as compared to
both normal controls and BPindividuals (e.g., Bora et al., 2007;
Glahn et al., 2007).
Note. BPI = Bipolar I disorder. BPII = Bipolar II disorder. BP+ = Bipolar disorder with psychotic features. BP- = Bipolar disorder
•

without psychotic features.
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Research Aims and Study Hypotheses
Based on these considerations, the goal of this study was to systematically
examine learning and memory for verbal and nonverbal (i.e., visual) information in
individuals with BP with and without psychosis in order to determine whether differential
impairments exist that are associated with psychosis. A secondary purpose of this study
was to compare the two BP groups to a group of individuals diagnosed with
schizophrenia on the same measures of verbal and visual learning and memory, again to
investigate whether these impairments differentiate among the groups either with regard
to severity or pattern of deficit.
To accomplish these aims, two parallel measures were selected in addition to a
standard battery of tests that allow for the examination of encoding, storage, and retrieval
processes for verbal and nonverbal memory. These measures were selected because they
have been previously used to assess memory functioning in affective and psychotic
disorders, and have demonstrated reliability and validity in these populations. The
California Verbal Learning Test (CVLT; Delis, Kramer, Kaplan, & Ober, 1987) was used
to assess verbal/auditory learning and memory, while memory for nonverbal/visual
information was assessed using the Biber Figure Learning Test-Extended (BFLT-E;
Glosser, Deutsch, Cole, & Corwin, 1997). These measures were administered to four
groups, specifically 1) normal controls (NC), 2) BP without psychosis (BP-), 3) BP with
psychosis (BP+), and 4) schizophrenia (SZ). Comparisons among the groups were made
on CVLT and BFLT-E scores sensitive to encoding, storage and retrieval processes.
Given what appears to be the primary role of working memory deficits and
executive function deficits in psychotic BP (and in psychosis more generally) our
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overarching hypothesis was that participants with psychiatric disorders with psychotic
features would perform more poorly on measures of verbal and nonverbal learning and
memory than those without psychosis. These deficits are primarily due to 1) limitations
in short-term memory capacity for verbal and nonverbal information (Phonological Loop
and Visuospatial Sketchpad) and 2) deficits in executive functions. Deficits in short-term
memory limits the amount of information that can be rehearsed and thus encoded into
long term memory, while deficits in executive function disrupt strategies used to
efficiently encode and later retrieve information. Because patients without psychosis
demonstrate limited short-term memory capacity but do not demonstrate executive
function deficits, it is anticipated that while learning may proceed at a slower rate than
what is expected in normals, organizational and retrieval strategies would remain
relatively intact in the BP without psychosis group. It also appears that there is a dosedependent relationship between psychosis and neurocognitive impairment in psychotic
disorders, such that patients with schizophrenia exhibit more severe deficits than those
with schizoaffective disorder, who in turn exhibit more severe deficits than those with
affective disorders. Thus, it was also expected that learning and memory would be better
preserved in the BP with psychotic features group than in the schizophrenia group.
Based on these considerations and the literature reviewed, the following
hypotheses were made according to predictions based on deficits in short-term memory
and executive functions:

Hypothesis 1: Across all memory scores, degradation in learning and memory were
expected to be present across all groups based on severity of psychosis, so that the NC
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group was expected to exhibit normal performance, with the BP- group exhibiting the
least severe deficits, followed by the BP+, and finally the SZ group, which was expected
to perform the worst. These differences between groups were expected to be statistically
significant (p < .05).

Hypothesis 2: In addition to a degradation in memory performance across the clinical
groups, the BP- group was expected to exhibit relative sparing of ability on memory test
scores that reflect strategy-based deficiencies in learning (e.g., semantic clustering) and
retrieval (e.g., normal recall vs. recognition discrepancies), and was not expected to differ
from the NC group on these measures. However, the psychosis groups were expected to
perform significantly worse (p < .05) than the BP- and NC groups on these measures.

Hypothesis 3: No specific hypotheses were made regarding the interaction between
lateralization effects in BP with or without psychosis given the current lack of
information in this area. However, given that visual working memory deficits have been
suggested as an endophenotype for psychosis and that the findings regarding differential
hemispheric involvement in BP have been mixed, it was hypothesized that visual
memory performance would be relatively preserved in the BP- group and impaired in the
BP+ group.
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CHAPTER 3:
METHOD
Participants
Twenty-five individuals with BP with psychotic features (BP+), 25 with BP
without psychotic features (BP-), 25 individuals with schizophrenia (SZ), and 25 normal
controls (NC) were included in this study. The participants were members of either the
University of Nevada, Las Vegas community or the Las Vegas community in general,
who were recruited as part of ongoing research studies investigating the neurocognitive
functioning of individuals with affective and psychotic disorders. All participants were
required to be between the ages of 18 and 65, and demonstrated no evidence of
significant vision impairment as assessed in-session. In addition to these inclusionary
criteria, the following exclusionary criteria were applied to all participants:
a) English as a secondary language, as determined via self-report.
b) A previous traumatic brain injury, as determined via self-report and
medical record review.
c) A neurological or seizure disorder, as determined via self-report and
medical record review.
d) Previous brain surgery, as determined via self-report and medical record
review.
e) A diagnosis of a chronic medical condition which has the potential to
adversely affect central nervous system functioning (e.g., liver disease,
HIV), as determined via self-report and medical record review.
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f) A current or recent (i.e., within the previous 6 months) diagnosis of a
substance use disorder, as determined via the administration of the
Structured Clinical Interview for the DSM-IV-TR (First, Spitzer, Gibbon,
& Williams, 2002).
g) Current (i.e., within the previous week) use of a prescribed or over the
counter medication which has CNS effects, with the exception of
medications that have been prescribed specifically for the purpose of
treating and/or regulating BP or SZ and their associated symptoms, as
determined via self-report and medical record review.
h) A hearing impairment which would interfere with ability to understand
verbal communication.
i) Corrected vision worse than 20/50 as determined via the administration of
a Visual Acuity test.
j) A diagnosis of a mood episode in the past month.
Furthermore, the following exclusionary criteria were applied to the NC participants:
a) A diagnosis of an Axis I disorder, as determined via the administration of
the Structured Clinical Interview for the DSM-IV-TR (First, Spitzer,
Gibbon, & Williams, 2002).
b) A diagnosis of BP, major depressive disorder, or SZ in a first-degree
relative, as determined via self-report using a standardized interview.
Measures
A battery of measures was selected to assess for diagnosis(es), as well as for
symptoms, intellectual ability, and verbal and nonverbal memory. As previously
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mentioned, these assessments were administered as part of a more extended
neuropsychological battery.
Diagnostic and Clinical Symptom Measures
Structured Clinical Interview for the DSM-IV-TR. The Structured Clinical
Interview for DSM-IV-TR Axis I Disorders (SCID; First, Spitzer, Gibbon, & Williams,
2002) is a semi-structured interview that was developed for the purpose of diagnosing
DSM-IV Axis I disorders and which is appropriate for use with both psychiatric and
general medical patients, as well as individuals from the community, for whom no
psychiatric diagnosis is expected. The interview is most commonly used with individuals
age 18 or older with an eighth grade education or higher. The SCID was administered by
qualified researchers trained in the DSM-IV-TR diagnostic system (APA, 1994) and will
be used to establish the presence (or absence) of DSM-IV Axis I psychiatric disorders.
The inpatient version of the SCID (SCID-I) was used in this study. This version
contains 10 modules, which are designed to assess for the presence of mood episodes,
psychotic symptoms, psychotic disorders, mood disorders, substance use disorders,
anxiety disorders, somatoform disorders, eating disorders, adjustment disorders, and
optional disorders. All 10 modules were administered to each participant, as well as the
screening module at the beginning of the SCID-I. The screening module consists of 12
questions which elicit basic information regarding possible diagnoses. This information
was then used to guide the administration of more probing questions later in the interview.
Each symptom in the SCID were rated on a scale of 1 to 3 (1 = symptom is absent; 2 =
symptom is sub-threshold; 3 = symptom is present). Specific DSM-IV Axis I diagnoses
were made following the scoring of each module. Regarding the psychometric properties

54

of the SCID-I, inter-rater reliability have been found to be excellent, with Kappa values
ranging from .71 to .97, with an average Kappa value of .85 (Ventura, Liberman, Green,
Shaner, & Mintz, 1998). Furthermore, the SCID-I has demonstrated high validity for the
diagnosis of schizophrenia and bipolar disorder (Steiner, Tebes, Sledge, & Walker, 1995),
with good sensitivity (.89), specificity (.96), and agreement (.86) when compared to best
estimate diagnoses made by psychiatrists on first-admission psychotic patients (Fennig,
Craig, Lavelle, Kovasznay, & Bromet, 1994).
While some participants demonstrated sub-threshold symptoms, any participant
(with the exception of normal controls) who had experienced a depressive, manic, or
mixed episode within the month prior to testing was excluded from the study, but was
offered the opportunity to participate following a month of euthymia.
The Young Mania Rating Scale. The Young Mania Rating Scale (YMRS; Young,
Biggs, Ziegler, & Meyer, 1978) is an eleven-item clinician administered rating scale
which is used to determine the presence and severity of symptoms of mania. The YMRS
is not designed to be a diagnostic tool, but is meant to be used as a symptom rating scale
in individuals previously diagnosed with BP. The scale was administered by a trained
clinician, who conducted an interview and subsequently assigned a symptom severity
rating for each item based on the behavioral observations made by the clinician, as well
as the participant’s self-report of symptom severity over the previous 2 weeks. Each item
was rated on a scale of 0 (absent) to 4 (overtly present), with the exception of four items
which were weighted doubly on a scale of 0 to 8. A score of four or less on the YMRS is
generally considered to indicate an asymptomatic state (with regards to symptoms of
mania).
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The Hamilton Depression Rating Scale. The Hamilton Depression Rating Scale
(HAM-D; Hamilton, 1960, 1967) is a frequently used clinician-administered rating scale
which assesses symptoms of depression as delineated by the DSM-IV. While the scale
does help the clinician determine the severity any symptoms present, the HAM-D is not
intended to be used as a diagnostic instrument. The current study used an abbreviated 21item version of the HAM-D (HAM-D21). Symptoms for which ratings were made
included depressed mood, as well as vegetative symptoms of depression, cognitive
symptoms of depression, and comorbid anxiety symptoms; this version did not assess for
the presence of disturbances in the areas of sleeping habits, eating habits, or
attention/concentration as related to the presence of depression. Each item was rated on a
Likert scale ranging 0 to 2, 3, or 4 for a total of 63 possible points. A score of 8 or less
was considered to be indicative of a relatively asymptomatic (i.e., euthymic) state, while
a score which fell above this cutoff was indicative of the presence of significant
symptoms of depression, with greater severity being associated with greater scores. The
scale was administered by a trained clinician, who conducted an interview and
subsequently assigned a symptom severity rating for each item based on the behavioral
observations made by the clinician, as well as the participant’s self-report of severity of
symptoms over the prior 2 weeks.
Regarding the psychometric properties of the HAM-D21, studies have found
evidence in support of high internal consistency, as well as construct validity as
demonstrated via the pattern of correlations between the HAM-D21 and other measures of
depression, anxiety, and depression-relevant cognition. Furthermore, factor analyses of
the full (23-item) version of the HAM-D (HAM-D21), as well as a 17-item abbreviated
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version (HAM-D17), have yielded four factors, which have accounted for 49% and 53%
of the variance, respectively, in the responses of participants (Dozois, 2003). Thus the
HAM-D21 has been demonstrated to be a valid and reliable assessment tool when used to
rate the severity of depression-related symptomatology.
The Brief Psychiatric Rating Scale. The Brief Psychiatric Rating Scale (BPRS;
Overall & Gorham, 1962) is an 18-item scale which is used to rate the presence and
severity of a number of psychiatric symptoms, as well as to track temporal changes in
symptomatology. Symptoms are rated following a 15-20 minute semi-structured
symptom ratings interview. Rated symptoms include somatic concern, anxiety,
emotional withdrawal, conceptual disorganization, guilt feelings, tension, mannerisms
and posturing, grandiosity, depressive mood, hostility, suspiciousness, hallucinatory
behavior, motor retardation, uncooperativeness, unusual thought content, blunted affect,
excitement, and disorientation. Each symptom is rated on a 7-point Likert scale, with the
following ratings representing the following corresponding levels of severity: 1 = not
present; 2 = very mild; 3 = mild; 4 = moderate; 5 = moderately severe; 6 = severe; and, 7
= extremely severe. Some items are rated according to the individual’s self-report, while
others are rated based on the clinician’s observations.
For each individual, four factor scores were calculated in addition to the total
score. Mueser, Curran, and McHugo (1997) conducted an exploratory factor analysis of
the BPRS in a sample of 474 individuals with schizophrenia, followed by a confirmatory
factor analysis in a separate sample of 327 individuals with schizophrenia. A four-factor
solution was found in the exploratory analysis and was confirmed via the confirmatory
factor analysis. The first factor, named Thought Disturbance, is comprised of items 8
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(Grandiosity), 11 (Suspiciousness), 12 (Hallucinatory Behavior), and 15 (Unusual
Thought Content). The Thought Disturbance factor is thus considered to be a reflection
of the positive symptoms (including hallucinations and delusions) commonly associated
with schizophrenia. The second factor, named Anergia, includes items 3 (Emotional
Withdrawal), 13 (Motor Retardation), 14 (Uncooperativeness), and 16 (Blunted Affect).
The Anergia factor is therefore thought to be an indication of the negative symptoms
generally related to schizophrenia. The third factor, named Affect, consists of items 1
(Somatic Concern), 2 (Anxiety), 5 (Guilt Feelings), 9 (Depressive Mood), and 10
(Hostility). The Affect factor is thus considered to be a reflection of emotional
disturbances. Finally, the fourth factor, named Disorganization, is comprised of items 4
(Conceptual Disorganization), 6 (Tension), and 7 (Mannerisms and Posturing). The
Disorganization factor is therefore thought to reflect the symptoms of disorganized
behavior often associated with schizophrenia. Items 17 (Excitement) and 18
(Disorientation) were not included in the final reported four-factor structure due to the
inconsistent loadings of these items on the exploratory factor analysis.
Regarding its psychometric properties, the BPRS has been found to have high
rates of agreement for the rating of positive symptoms of schizophrenia, as well as for the
symptoms of depression and mania (Andersen, Korner, Larsen, & Schultz, 1993).
Additionally, overall inter-rater reliability coefficients have been found to range from
0.85 to 0.92, with at least one sample which was largely comprised (i.e., 94% of the
sample) of individuals diagnosed with schizophrenia, bipolar disorder, or major
depression (Engelsmann & Formankova, 1967; Bell, Milstein, Beam-Goulet, Lysaker, &
Cicchetti, 1992; Ligon & Thyer, 2000). Other studies have found the inter-rater
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reliability of the BPRS to be satisfactory when used to rate the psychiatric symptoms of
individuals with schizophrenia (e.g., Andersen, Larsen, Schultz, & Nielsen, 1989).
Intellectual Functioning
Current intellectual functioning was assessed using a dyadic short form of the
Wechsler Adult Intelligence Scale – Third Edition (WAIS-III; Wechsler, 1997) in which
the Vocabulary and Block Design subtests are used to estimate one’s current Full Scale
Intelligence Quotient (IQ) based on a series of regression equations (Ringe, Saine, Lacritz,
Hynan, & Cullum, 2002). The equation which was used has been found to estimate Full
Scale IQ within 10 points in 81-93% of a mixed neurological/psychiatric sample (Ringe
et al., 2002).
Additionally, premorbid intellectual functioning was assessed by taking an
average of the scaled scores obtained on the Vocabulary and Information subtests from
the WAIS-III (Wechsler, 1997). These subtests have been shown to have the highest
reliability coefficients (.89 and .96, respectively) among the subtests of the WAIS-III
Verbal Comprehension Index (Vanderploeg, Schinka, & Axelrod, 1996). Furthermore,
they are considered to be “hold” tests which change little over time, including following
brain dysfunction (Bilder et al., 1992; Vanderploeg, Schinka, & Axelrod, 1996).
WAIS-III Vocabulary Subtest. The Vocabulary subtest of the WAIS-III is
comprised of 33 items of increasing difficulty which the participant is asked to define.
Each response is given a score of 0, 1, or 2 points for a total possible score 66. Higher
scores reflect more accurate definitions. Administration of the subtest is discontinued
following four consecutive scores of 0. The Vocabulary subtest has demonstrated good
reliability, reported to be approximately .96 (Vanderploeg, Schinka, & Axelrod, 1996).
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WAIS-III Block Design Subtest. The Block Design subtest of the WAIS-III is
comprised of 14 designs of increasing difficulty and complexity which the participant is
asked to recreate using a set of either four (on earlier items) or nine (on more advanced
items) blocks. The blocks are identical and each have two red sides, two white sides, and
two sides that are half red and half white as divided diagonally. Items are scored
according to accuracy with bonuses awarded for rapid completion times. The number of
possible points awarded for each item varies according to the complexity of the item and
the presence or absence of time bonuses. Overall, one can earn up to 68 points on the
subtest. Administration of the subtest is discontinued following three consecutive scores
of 0. A score of 0 is awarded if the design is completed incorrectly, or if the design is not
completed correctly within the time limit. The time limit for each item varies according
to the complexity of the item, with the time limit of the most complex items being 2
minutes.
WAIS-III Information Subtest. The Information subtest of the WAIS-III is
comprised of a series of 28 increasingly difficult questions which are thought to test one’s
general fund of information. The items require broad knowledge of current and historical
facts (e.g., “Who painted the Sistine Chapel?”). Items are given a score of either 0 or 1
depending on the correctness of the individual’s response, allowing for a total possible
score of 28. No points are given for incorrect guesses or partial answers. The subtest is
discontinued following 6 consecutive scores of zero.
Verbal Learning and Memory
California Verbal Learning Test. The California Verbal Learning Test (CVLT;
Delis, Kramer, Kaplan, & Ober, 1987) is used to measure declarative verbal learning and
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memory via the repeated administration of word lists across trials, as well as the
participant’s attempted recall of the lists. The measure is comprised of two lists of
sixteen common shopping list items, List A (i.e., “Monday’s Shopping List”) and List B
(i.e., “Tuesday’s Shopping List”). List A is composed of shopping items in the categories
of spices and herbs, household tools, fruits, and articles of clothing; List B is comprised
of shopping items in the categories of spices and herbs, fruits, fish, and cooking utensils.
List A is administered five consecutive times (Trials 1–5), with the participant being
asked to recall as many words as possible following each trial, thus providing a measure
of immediate free recall. List B, a distractor list, is then administered once, after which
the participant is asked to recall as many words as possible from that list. The participant
is then immediately asked to recall as many words as possible from List A as a measure
of short-delay free recall and retroactive interference. Next, the participant is asked to
recall as many words as possible from each category from List A, with the administrator
providing cues for each category (e.g., “Tell me all of the shopping items from the
Monday list which are fruits.”), providing a measure of short-delay cued recall.
Following approximately a twenty-minute delay, the participant is again asked to
remember as many words as possible from List A, providing a measure of long-delay free
recall, as well as to recall as many words as possible from List A with the administrator
providing cues, providing a measure of long-delay cued recall. Finally, the participant is
read a list of forty words – some of which were on List A, some of which on List B, and
some of which were on neither – and asked to determine whether or not each word was
on List A, providing a measure of long-delay recognition. Overall, the CVLT serves as a
measure of learning across trials, whether the participant employs the use of various

61

learning strategies (i.e., serial versus semantic learning), retrieval/encoding difficulties,
recognition, interference effects (both proactive and retroactive), hit rate, response bias,
and discriminability.
Visual Learning and Memory
Biber Figure Learning Test-Extended. The Biber Figure Learning Test-Extended
(BFLT-E; Glosser, Deutsch, Cole, & Corwin, 1997) is a measure of nonverbal (i.e.,
visual) or learning and memory. The BFLT-E is a modified version of the original Biber
Figure Learning Test and has previously been described as a visual analog of the
California Verbal Learning Test (Kurzman, 1996; Tracy et al., 2001; Glosser, Cole,
Khatri, DellaPietra, & Kaplan, 2002). Similar to the CVLT, the BFLT-E is constituted of
a series of five learning trials of a sequence of fifteen geometric designs constructed of
simple shapes (i.e., circles, squares and triangles) which are used to construct novel
stimuli. Each figure is shown for approximately 3 seconds during each round of item
administration, and the participant is asked to draw as many shapes as possible from
memory, in no particular order, following each trial, thus providing a measure of
immediate free recall. A distractor set is then administered, with the individual being
shown fifteen different figures and asked to reproduce as many as possible. Next, the
participant is asked to reproduce as many of the figures as possible from the first series
set of designs, providing a measure of long-delay free recall, after which a recognition
task mirroring that of the CVLT is administered. Finally, the participant is shown the
figures from the first series for approximately three seconds each and is immediately
asked to subsequently draw each figure; if there are any figures which the participant
does not draw correctly immediately following the three second viewing time, he/she is
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asked to copy the figure while viewing it directly. Each design is scored on a range of 0
to 3 according to the accuracy of the reproduction.
The inter-tester reliability for the BLFT-E has been found to be .98 (Glosser, Cole,
Khatri, DellaPietra, & Kaplan, 2002). Similarly, test-retest reliability and criterion
validity have both been found to be good (Glosser et al., 2002). As previously mentioned,
the BFLT-E has been described as a visual analog to the CVLT (Tracy, et al., 2001;
Glosser, Cole, Khatri, DellaPietra, & Kaplan, 2002). While the CVLT and BFLT-E are
not identically matched regarding difficulty level and item content, they can serve as
comparative measures for the domains of verbal and non-verbal (i.e., visual) learning and
memory, respectively (Tracy et al., 2001).
Procedure
The schizophrenia group was comprised of individuals who had participated in a
research study conducted in 2006. These participants were recruited from Mojave Adult,
Child, and Family Services in Las Vegas, NV, which is an outpatient facility which
provides community services to the mentally ill.
Participants for each of the bipolar groups, as well as for the normal control group,
were recruited through referrals from local physicians and mental health agencies, fliers
posted on local campuses and around the community, advertisements posted in press
releases and on listserves, and verbal advertisements at local support group meetings.
Participants initially contacted the research team by telephone or e-mail. An initial phone
screen was conducted during which time verbal informed consent was obtained for the
procedures used in the phone screen (see Appendix I). The screen requested information
relevant to study inclusion and exclusion criteria. If it was determined that the individual
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may have met criteria to participate in the study, an initial evaluation session was
scheduled in order to conduct a more extensive interview to establish the diagnosis and
determine eligibility to participate based on the other aforementioned inclusion and
exclusion criteria.
In addition to the participants included in the study, a total of 270 consecutive
individuals contacted our research team but did not go on to participate. Of those 270
individuals, we lost contact with 100 (e.g., they failed to return our phone calls), 18 were
scheduled to be included as participants but did not come to the scheduled appointment(s),
and 13 were no longer interested in the research at the time of the phone screen. The
remaining 139 individuals were excluded from participation in the study. See Table 2 for
a visual representation of the reasons for exclusion.
The interviews, questionnaires and neuropsychological tests used in this study
were administered as part of a larger battery of tests being conducted in the
Neuropsychology Research Lab at UNLV. Administration was scheduled across two 3hour sessions, with the entire battery lasting for a total of approximately 6 hours. The
initial session consisted of the administration of diagnostic and clinical symptom
measures, while the second session consisted of the administration of the neurocognitive
measures. When possible, both sessions were be scheduled on the same day, with a 1hour lunch break in between sessions. Furthermore, several mandatory breaks were
scheduled into each evaluation session in order to circumvent fatigue and maintain
motivation. All participants were compensated for their time. If the participant was a
psychology student seeking research credit for a psychology class, he/she was
compensated one research credit per hour completed. If the participant was from the
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Table 2. Summary of Reasons for Exclusion from Study for the BP+, BP-, and NC
Participants.
Number
% of those
Reason for Exclusion
excluded
excluded
25.1
Comorbid Axis I disorder
35
23.7
Sub-threshold psychiatric symptomatology
33
10.1
English as a second language
14
10.1
Neurological disorder
14
6.5
Traumatic Brain Injury (TBI)
9
4.3
Medical disorder interfering with the Central Nervous System
6
4.3
Instable mood episodes
6
3.6
Older than 65
5
2.9
Refused to participate in phone screen
4
2.9
Was calling for a relative
4
2.2
First-degree relative of an individual with bipolar disorder
3
4.2
Other
6
100.0
Total
139
Note. BP+ = Bipolar disorder with psychotic features. BP- = Bipolar disorder without
psychotic features. NC = Normal control group.

community or was a university student who was not seeking research credit, he/she was
be compensated $5.00 for each hour completed, and also given a $30.00 bonus for
completion of all testing procedures, for a total of approximately $60.00.
During the first session, each participant was given an Informed Consent (see
Appendix B for the full consent forms for individuals recruited from the community and
for individuals recruited from UNLV). The consent form was read aloud in its entirety to
each participant, and an opportunity was provided for all questions/concerns to be
addressed and clarified. Both the participant and the researcher signed two Informed
Consents – one for the researcher to keep for the participant’s file and one for the
participant to keep for his/her own records and information. Following informed consent,
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a Demographics Questionnaire was administered in order to gain in-depth information
regarding the participant’s personal and family history (see Appendix I for the full
Demographics Questionnaire). The participant was then administered the battery of
interviews, questionnaires, and neurocognitive tests in the following order: 1) Structured
Clinical Interview for DSM-IV-TR; 2) Hamilton Depression Rating Scale; 3) Young
Mania Rating Scale; and, 4) Brief Psychotic Rating Scale. If the participant did not meet
diagnostic criteria based on the Structured Clinical Interview for DSM-IV, the study was
discontinued. If diagnostic criteria were met, the Biber Figure Learning Test – Extended
and the California Verbal Learning Test were administered as part of a more extensive
test battery. All assessment procedures were administered by doctoral level graduate
students who had been extensively trained to do so in a reliable and valid manner.
Data Entry and Analyses
Data Entry and Screening
All tests were scored according to standardized procedures by two trained
individuals. In the event that a disagreement occurred regarding the scoring of a measure
(as occurred at times with the BFLT-E), a third opinion (Daniel N. Allen, Ph.D.) was
used to resolve the discrepancy. Data was entered twice into a Microsoft Access
database, and SPSS version 16.0 was be used to analyze the data.
Before the primary hypotheses were evaluated, raw data from the
neuropsychological measures was examined to confirm that assumptions for multivariate
analysis of variance (MANOVA) were met (i.e., independence of samples, homogeneity
of variance, and normality of the distribution). Skewness and kurtosis were examined in
order to ensure that the variables are normally distributed. In the event that fewer than
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10% of the variables were found to be non-normally distributed, appropriate
transformations would be used in order to increase the normality of the distribution
(Tabachnick & Fidell, 2001). In cases where more than 10% of the variables are nonnormally distributed, nonparametric analyses would be conducted by rank ordering the
data and subsequently running standard parametric analyses. Furthermore, box plots
were utilized in the event of outliers, such that an outlier was defined as a score which
fell 3.0 standard deviations either above or below the mean. When outliers were
identified, the individual data for those participants were examined in order to determine
whether they were representative of valid cases. If the case was in fact determined to be
valid, the data was to be kept but would be converted in order to decrease its influence on
the data, prior to multivariate analysis.
Data Analyses
Preliminary analyses. Several preliminary analyses were run before performing
the primary analyses. Specifically, descriptive statistics were calculated for the groups
for the demographic variables of age, education, estimated IQ, ethnicity, and gender. The
demographic characteristics of the groups were compared using either analysis of
variance (ANOVA) or chi-square in order to test for the presence of significant
differences on these demographic variables. Significant demographic differences
between the groups were not anticipated, however, since efforts were made to match the
groups on these variables.
In addition, clinical variables were reported via the use of descriptive statistics,
specifically regarding length of illness, current symptomatology and severity of
symptoms (as measured via the Young Mania Rating Scale and the Hamilton Depression
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Rating Scale), total number of mood episodes, number of hospitalizations, and current
medication status.
Main analyses. The general approach to analyzing the data involved comparisons
among multiple groups on multiple dependent measures, making multivariate analysis of
variance (MANOVA) the most appropriate approach. More specifically, in order to
determine if predicted differences in memory functioning were present, the four groups
(i.e., NC, BP-, BP+, and SZ) served as the between subjects factor and were compared on
the verbal and visual measures of learning and memory, which served as dependent
variables in the analyses.
In order to select dependent variables to be included in the MANOVAs, studies
regarding the factor structure of the CVLT were consulted. These studies generally
suggested that between four and six factors account for the majority of variance among
the CVLT scores (Donders, 2008; Delis et al., 2000). Factors that were particularly
relevant to the current study and that could be calculated for both the CVLT and BFLT-E
included the General Memory, Short-term Memory (also referred to as the Attention
factor), Primacy/Recency Memory, and Response Discrimination Memory factors. The
scores used to measure each of these factors and which were used as the dependent
variables in the MANOVAs are presented in Table 3.
Additionally, a derived score was developed by subtracting total correct on List A
Trial 5 from the total number correct on the Recognition Trial. Large values for this
score were thought to indicate deficient retrieval processes.
Because the hypotheses were delineated by differences in memory functioning that
result from impaired short-term memory versus impaired executive function, two
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Table 3. Memory Factors and Corresponding Variables.
Memory Factor

CVLT

General

Short Delay Correct
Long Delay Correct
Short-term
List A Trial 1 Correct
List B Correct
Primacy/Recency
% Recall Primacy Region
% Recall Middle Region
% Recall Recency Region
Response Discrimination Free Recall Intrusions
Response Bias
Recognition False Positives

BFLT-E
Short Delay Correct
Long Delay Correct
Trial 1 Correct
Distractor Correct
% Recall Primacy Region
% Recall Middle Region
% Recall Recency Region
Free Recall Intrusions
Response Bias
Recognition False Positives

Note. CVLT = California Verbal Learning Test. BFLT-E = Biber Figure Learning TestExtended.

MANOVAs were run. The first included memory factors thought to be minimally
influenced by executive function deficits, including the General Memory and Short-term
Memory factors. The second MANOVA included those scores that are thought to be
particularly susceptible to strategy-based memory failures, including the
Primacy/Recency and Response Discrimination Memory factors, as well as the derived
Recall/Recognition derived score.
Because memory scores were derived for both the CVLT and the BFLT-E, a within
subjects factor was also included in the MANOVAs that represented the type of
information contained in each task (i.e., verbal versus visual). Thus, Hypotheses 1, 2,
and 3 were evaluated using two MANOVAs, each including one between subjects factor
for group membership (NC, BP-, BP+, SZ), one within subjects factor for type of
memory tested (verbal versus visual), and the memory test scores as dependent variables.
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If the overall F for any MANOVA was significant, univariate F tests and post hoc
comparisons were subsequently used to examine differences among groups on individual
test scores.
Hypothesis 1 will have been supported if significant between group differences
were present for the MANOVA examining memory tests scores that are not sensitive to
executive function deficits (i.e., the General and Short-term Memory factors), such that
the BP- and BP+ groups did not differ from each other, but performed significantly worse
than the NC and significantly better than the SZ group.
Hypothesis 2 will have been supported if the MANOVA indicated significant
between-subjects effects in which the BP- group 1) did not differ from controls on the
memory tasks thought to be dependent on intact executive functions, and 2) performed
significantly better than the BP+ and SZ groups. It was also anticipated that the BP+
group would perform better than the SZ group.
Finally, Hypothesis 3 will have been supported if there were significant effects for
both of the MANOVAs indicating that the BP- group did not differ from the NC group on
the visual memory tasks, but instead significantly differed from the BP+ and SZ groups.
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CHAPTER 4
RESULTS
Data Screening
Preliminary analyses were conducted and raw data were examined in order to
verify that the assumptions for MANOVA were met prior to the main analyses.
Specifically, descriptive statistics and box plots were used to identify potential outliers,
with outliers being defined as scores falling 3 standard deviations above or below the
mean. All outliers identified were found to be the result of data entry errors and were
subsequently corrected. Similarly, skewness and kurtosis were examined for continuous
variables in order to verify that these variables were normally distributed, with the criteria
for normal distribution being skewness and kurtosis of less than ±1.0. Although all
variables for the first MANOVA were found to be normally distributed, the majority of
the variables (12 of 14; 85.71%) for the second MANOVA were found to have skewness
and/or kurtosis of greater than or equal to ±1.0, including: California Verbal Learning
Test (CVLT) % Primacy Region, CVLT % Middle Region, CVLT % Recency Region,
CVLT Free Recall Intrusions, CVLT Recognition False Positives, CVLT
Recall/Recognition Score, Biber % Primacy Region, Biber % Middle Region, Biber %
Recency Region, Biber Free Recall Intrusions, Biber Recognition False Positives, and
Biber Recall/Recognition Score. All 14 variables for the second MANOVA were
therefore converted to ranked scores to allow for a non-parametric MANOVA to be
computed.
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Preliminary Analyses
Subsequent to initial data screening, preliminary analyses were conducted to
evaluate for the presence of differences among the groups (i.e., SZ, BP+, BP-, and NC)
on a number of demographic variables, including gender, handedness, ethnicity, and
marital status. Groups were also compared on several demographic variables which have
been demonstrated to affect performance on neurocognitive measures, including age,
education, and current and premorbid IQ. Additionally, groups were compared on a
number of clinical characteristics commonly associated with neurocognitive performance,
including number of hospitalizations, length of illness duration, global assessment of
functioning, current symptomatology (as evaluated via the Hamilton Depression Rating
Scale for symptoms of depression, the Young Mania Rating Scale for symptoms of mania,
and the Brief Psychiatric Rating Scale for psychiatric symptoms), and current medication
status, as well as proportion of individuals with bipolar II disorder (as opposed to bipolar
I disorder) in the BP+ and BP- groups. Continuous variables were evaluated via analysis
of variance (ANOVA), while categorical variables were compared via chi-square. When
significant differences were found, post-hoc tests were used to identify specific betweengroup differences.
The demographic characteristics of the sample, as well as the results of the
statistical analyses comparing the groups on these variables, are presented in Table 4. No
significant differences were found among the groups for gender, chi-square (3) = 5.77, p
= .123 or handedness, chi-square (3) = 7.56, p = .056. Conversely, significant group
differences were found for age, F (3, 96) = 5.59, p = .001, with post-hoc analyses
indicating that the schizophrenia group was significantly older than the BP- and NC
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Table 4. Demographic Characteristics of the Groups.
Variables

Age

SZ (n=25)
Mean
SD
43.00 12.58

Group
BP+ (n=25)
BP- (n=25)
Mean
SD
Mean
SD
35.60
13.61 32.84
12.98

NC (n=25)
Mean
SD
28.96
10.84

F
5.59

Education

12.26

14.40

14.12

1.45

5.97

Current IQ

77.33

15.24

31.21

2.45

38.47

Premorbid IQ

2.10

11.63 106.24

6.70

2.71
%
32
84

12.56
%
64
100

2.52

14.44

2.29

10.20 106.89
2.01

13.20 103.62

12.22

1.57
%
56
80

11.80
%
56
96

χ2
5.77
7.56
42.66

p
Scheffé
.001 SZ > BP, NC
.001 SZ < NC,
BP+, BP<.001 SZ < NC,
BP+, BP<.001 SZ < NC,
BP-, BP+
p
.123
.056
.011

Gender (% females)
Handedness (% right)
Ethnicity
Caucasian
40
60
76
44
African American
44
4
0
24
Hispanic/Latino
8
8
0
8
Asian American
4
8
8
8
Native American
0
4
0
0
Biracial
4
12
0
12
Other
0
4
8
4
Marital Status
16.99
.009
Single
96
60
72
56
LTR
0
40
28
44
Not reported
4
0
0
0
Note. SZ = Schizophrenia group. BP+ = Bipolar disorder with psychotic features group. BP- = Bipolar disorder without psychotic
features group. NC = Normal control group. SD = Standard deviation. IQ = Intelligence Quotient. LTR = Long-term relationship.
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groups. Significant group differences were also found for education, F (3, 96) = 5.97, p
= .001, current IQ, F (3, 96) = 31.21, p < .001, and premorbid IQ, F (3, 96) = 38.47, p
< .001. Post-hoc analyses indicated that the SZ group had significantly fewer years of
education, significantly lower current IQ, and significantly lower premorbid IQ than the
BP+, BP-, and NC groups. Finally, significant group differences were found for ethnicity,
chi-square (24) = 42.66, p = .011, and marital status, chi-square (6) = 16.99, p = .009.
The clinical characteristics of the sample, as well as the results of the statistical
analyses comparing the groups on these variables, are presented in Table 5. No
significant differences were found among the groups for length of illness, F (2, 66) = 0.88,
p = .421. Significant differences were found, however, for number of hospitalizations, F
(2, 72) = 7.82, p = .001, with post-hoc analyses indicating that the SZ group had
significantly more previous hospitalizations than the BP- group. Additionally, there were
significant group differences in global assessment of functioning (GAF) scores, F (3, 82)
= 88.93, p < .001, with post-hoc analyses indicating that the SZ group had significantly
lower GAF scores than the BP+, BP-, and NC groups, and that the BP+ and BP- groups
also had significantly lower GAF scores than did the NC group.
Several measures of current symptomatology were used to evaluate for the
presence of depression and mania in the BP+, BP-, and NC groups, and for the presence
of psychiatric symptoms in all groups. Significant between-group differences were found
for all symptom rating measures. Specifically, significant differences were identified for
the presence of symptoms of depression, as measured via the Hamilton Depression
Rating Scale, F (2, 68) = 14.12, p, < .001, as well as symptoms of mania, as measured by
the Young Mania Scale, F (2, 68) = 11.68, p < .001. Post-hoc analyses indicated that,
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Table 5. Clinical Characteristics of the Groups.
Variables

Number of
hospitalizations
Illness duration
GAF
HAM-D21
YMRS
BPRS
TD
Anergia
Affect
Disorganization
Total Score

Bipolar II
Medication statusf
Antipsychotic
Mood stabilizer
Antidepressant
Anti-anxiety
Not medicated

SZ (n=25)
Mean
SD
5.36
5.41

Group
BP+ (n=25)
BP- (n=25)
Mean
SD
Mean
SD
2.88
3.47
1.12
1.51

NC (n=25)
Mean
SD

23.21a
32.81b

18.28
56.95c

13.91
13.18

19.24
62.64

12.05
11.64

88.13d

4.77

0.88
88.93

7.80
3.36

4.30
2.77

7.80
3.20

5.92
2.55

1.62e
0.43e

1.94
0.75

14.12
11.68

11.95
10.91

F
7.82

10.48

4.42

5.52e

1.99

4.60

0.91

3.44

1.58

35.14

9.76

5.32

4.62e

1.07

4.36

0.81

3.36

1.50

24.52

10.44

4.36

9.05e

2.38

9.96

3.21

5.20

2.60

13.29

5.96

2.56

3.38e

0.74

3.28

0.46

2.68

1.25

23.07

39.56

8.57

25.00e

3.48

24.48

4.11

16.44

7.51

56.59

%

%
8

%
40

%

χ2
7.02

96
60
0
16
4

56
80
36
32
12

32
36
52
8
20

0
0
0
0
100

22.04
10.01
17.11
4.92
3.03
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p
Scheffé
.001 SZ > BP.421
<.001 SZ < BP+,
BP- < NC
<.001 BP-, BP+ > NC
<.001 BP-, BP+ > NC
<.001 SZ > NC,
BP-, BP+
<.001 SZ > BP+,
BP-, NC
<.001 SZ, BP-,
BP+ > NC
<.001 SZ > BP+,
BP-, NC
<.001 SZ > BP+,
BP- > NC
p
.008
<.001
.007
<.001
.086
.220

Note. SZ = Schizophrenia group. BP+ = Bipolar disorder with psychotic features group. BP- = Bipolar disorder without psychotic
features group. NC = Normal control group. SD = Standard deviation. GAF = Global Assessment of Functioning. HAM-D21 =
Hamilton Depression Rating Scale. YMRS = Young Mania Rating Scale. BPRS = Brief Psychiatric Rating Scale. TD = Brief
Psychiatric Rating Scale Thought Disturbance factor.
a

n=19. bn=16. cn=22. dn=23. en=21. fGiven that none of the NC participants were taking any psychiatric medications, only the three

psychiatric groups (i.e., SZ, BP+, and BP-) were included in the chi-square analyses for medication status.
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although all groups were euthymic on average at time of testing, the BP+ and BP- groups
reported and demonstrated significantly more sub-threshold symptoms of both depression
and mania than did the NC group, although there were no significant differences between
the BP+ and BP- groups themselves.
Groups were also compared on total Brief Psychiatric Rating Scale (BPRS) scores,
as well as on four factor scores as identified by Mueser, Curran, and McHugo (1997).
Significant between group differences were found for the BPRS total score, F (3, 92) =
56.59, p < .001, with post-hoc tests indicating that the SZ group demonstrated
significantly more psychiatric symptoms at time of assessment than the BP+ and BPgroups (see Table 5, as well as Figure 2). Additionally, all psychiatric groups
demonstrated significantly more psychiatric symptoms than did the NC group, as would
be expected. Furthermore, there were significant differences among groups on the
following: the BPRS Thought Disturbance factor, a measure of the positive symptoms
commonly associated with schizophrenia, F (3, 92) = 35.14, p < .001; the Anergia factor,
a measure of the negative symptoms generally related to schizophrenia, F (3, 92) = 24.52,
p < .001; the Affect factor, a reflection of emotional disturbances, F (3, 92) = 13.29, p
< .001; and, the Disorganization factor, a measure of the symptoms of disorganized
behavior often exhibited in individuals with schizophrenia, F (3, 92) = 23.07, p < .001.
Post-hoc analyses indicated that the SZ group demonstrated significantly more symptoms
of thought disturbance and anergia than did the BP+, BP-, and NC groups, that the SZ,
BP+, and BP- groups demonstrated significantly more symptoms of affect than the NC
group, and that the SZ group demonstrated significantly more symptoms of
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Figure 2. Brief Psychiatric Rating Scale (BPRS) Factor and Total Scores for the
Groups.
5

4

Standard Scores

SZ
3
BP+
BP2
NC
1

0
TD

An

Aff

Dis

Total

Variables

Note. SZ = Schiozphrenia group. BP+ = Bipolar disorder with psychotic features group.
BP- = Bipolar disorder without psychotic features group. NC = Normal control group.
TD = BPRS Thought Disturbance factor. An = BPRS Anergia factor. Aff = BPRS Affect
factor. Dis = BPRS Disorganization factor. Total = BPRS Total Score.
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disorganization than the BP+, BP-, and NC groups, with the BP+ and BP- groups also
having demonstrated significantly more symptoms of disorganization than the NC group.
Given the significant differences in symptomatology in the groups, Pearson
correlations were used to evaluate the relationships between psychiatric symtpomatology
at time of testing and neurocognitive performance in the psychiatric groups (see Tables 6
and 7). Bonferroni corrections were used to account for inflated Type I error rates due to
multiple correlations. No significant relationships were found between the ratings of the
Young Mania Rating Scale or the Hamilton Depression Rating Scale and neurocognitive
performance. Additionally, only two significant relationships were found between the
Affect factor of the Brief Psychiatric Rating Scale, namely with CVLT % Recall Primacy
and Recency Region. Conversely, multiple significant relationships were found between
the remaining factor scores of the Brief Psychiatric Rating Scale, as well as the Total
Score of the Brief Psychiatric Rating Scale. In fact, significant relationships were found
for all variables with at least one of the remaining factor scores (i.e., Thought
Disturbance, Anergia, and Disorganization) and/or the Total Score, with the exception of
CVLT % Recall Primacy Region, Biber % Recall Primacy Region, Biber % Recall
Middle Region, Biber % Recall Recency Region, Biber Free Recall Intrusions, and Biber
Response Bias.
In other words, greater symptomatology at time of testing was generally
associated with more impaired neurocognitive functioning, although mood symptoms at
time of testing were not found to be significantly related to neurocognitive performance.
Notably, however, the presence of negative symptoms, in addition to positive symptoms,
did exhibit significant relationships with performance on neurocognitive variables,

79

Table 6. Pearson Correlation Coefficients between Symptomatology at Time of Testing
and Non-Strategy-Based Learning and Memory Variables.

YMRS

SD
-.10
-.08

CVLT Variables
LD
T1
-.04
-.06
-.22
.04

Dis
-.20
.19

SD
-.21
-.30

Biber Variables
LD
T1
-.16
-.37
-.42*
-.26

Dis
.01
-.17

HAM-D21
BPRS
-.57** -.62** -.50** -.56** -.49** -.57** -.39** -.44**
TD
-.54** -.58** -.55** -.41** -.56** -.53** -.48** -.47**
An
-.11
-.04
-.11
-.01
.04
-.01
-.11
-.01
Aff
-.47**
-.55** -.62** -.43** -.42** -.53** -.53** -.33*
Dis
-.65** -.74** -.59** -.54** -.61** -.67** -.47** -.57**
Total
Note. CVLT = California Verbal Learning Test. Biber = Biber Figure Learning TestExtended. SD = Short Delay. LD = Long Delay. T1 = Trial 1. Dis = Distractor. YMRS =
Young Mania Rating Scale. HAM-D21 = Hamilton Depression Rating Scale. BPRS =
Brief Psychiatric Rating Scale. TD = Brief Psychiatric Rating Scale Thought Disturbance
factor. An = Brief Psychiatric Rating Scale Anergia factor. Aff = Brief Psychiatric Rating
Scale Affect factor. Dis = Brief Psychiatric Rating Scale Disorganization factor. Total =
Brief Psychiatric Rating Scale Total Score.
*p < .05 (with Bonferroni correction, when p < .00625).
**p < .01 (with Bonferroni correction, when p < .00125).
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Table 7. Pearson Correlation Coefficients between Symptomatology at Time of Testing and Strategy-Based Learning and Memory
Variables.

YMRS

Pri
-.04
-.09

Mid
-.01
-.14

CVLT Variables
Rec
Int
RB
.02
.05
.03
.26
.07 -.22

RFP
-.16
-.05

Biber Variables
R/R Pri Mid Rec Int RB RFP
-.17 -.13 .08 .05 -.05 .00 -.23
.06 .03 .01 .00 .00 .19 -.27

R/R
.06
-.15

HAM-D21
BPRS
-.04
-.29
.21
-.33 -.43** -.37* -.28 .09 -.17 -.20 -.26 .06 -.48** -.35*
TD
-.18 -.03 -.02 -.16 -.14 .04 -.46** -.27
.24
-.39*
.17
-.30 -.56** -.20
An
-.42** -.09
.36* -.04 -.11
-.08
-.08 .05 -.11 .08 -.02 .21 -.18
-.14
Aff
-.03
-.44** .40** -.21 -.35* -.42** -.34 .10 .06 -.31 -.16 .05 -.41* -.45**
Dis
-.09
-.44** .40** -.35* -.56** -.40** -.32 .06 -.10 -.22 -.25 .16 -.60** -.46**
Total
Note. CVLT = California Verbal Learning Test. Biber = Biber Figure Learning Teset-Extended. YMRS = Young Mania Rating Scale.
HAM-D21 = Hamilton Depression Rating Scale. Pri = % Recall Primacy Region. Mid = % Recall Middle Region. Rec = % Recall
Recency Region. Int = Free Recall Intrusions. RB = Response Bias. RFP = Recognition False Positives. R/R = Recall/Recognition
Score. BPRS = Brief Psychiatric Rating Scale. TD = Brief Psychiatric Rating Scale Thought Disturbance factor. An = Brief
Psychiatric Rating Scale Anergia factor. Aff = Brief Psychiatric Rating Scale Affect factor. Dis = Brief Psychiatric Rating Scale
Disorganization factor. Total = Brief Psychiatric Rating Scale Total Score.
*p < .05 (with Bonferroni correction, when p < .00357).
**p < .01 (with Bonferroni correction, when p < .000714).
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suggesting that it may be beneficial to focus future research on the influence of both
positive and negative symptoms on impairment.
Significant group differences were also found for the proportion of individuals
with bipolar II disorder (as opposed to bipolar I disorder) in the BP+ and BP- groups, chisquare (1) = 7.02, p = .008. Specifically, 40% of the BP- group had been diagnosed with
bipolar II disorder, compared with only 8% of the BP+ group. As a result, the BP+ and
BP- groups were re-evaluated according to type of diagnosis (i.e., bipolar I versus bipolar
II disorder). Specifically, the groups were compared on age and education (see Table 8),
as well as the non-strategy and strategy-based learning and memory variables via
MANOVAs (see Table 9). Notably, the groups did not differ significantly on age or
education.

Table 8. Comparison of the Bipolar I and Bipolar II Disorder Groups on Age and
Education.
Variables

Group

BPI (n=38)
BPII (n=12)
Mean
SD
Mean
SD
F
p
35.21
14.20
31.08
9.38
0.88
.352
Age
2.43
14.92
2.23
0.68
.413
Education 14.26
Note. BPI = Bipolar I disorder group. BPII = Bipolar II disorder group. SD = Standard
deviation.
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Table 9. Results of the MANOVAs Comparing the Bipolar I and Bipolar II Disorder
Groups on Non-Strategy-Based and Strategy-Based Learning and Memory Variables.

Non-strategy-based learning and
memory variables
Strategy-based learning and
memory variables

F

p

1.10

.385

0.78

.683

Additionally, neither of the MANOVAs comparing the groups on the
neurocognitive variables yielded significant differences (for non-strategy-based learning
and memory variables, F (8,41) = 1.10, p = .385; for strategy-based learning and memory
variables, F (14, 35) = 0.78, p = .683). This overall similarity in performance between
the bipolar I and bipolar II disorder groups suggests that any differences in performance
found between the BP+ and BP- groups were likely not due to differences in the make-up
of the groups in terms of percentage of individuals diagnosed with bipolar I versus
bipolar II disorder.
There were also significant differences in medication status among the groups,
even with NCs excluded from the analyses. Differences in medication status were as
follows: regarding antipsychotics, chi-square (2) = 22.04, p < .001, as 96% of the SZ
group, 56% of the BP+ group, and 32% of the BP- group were taking antipsychotics at
time of testing; regarding mood stabilizers, chi-square (2) = 10.01, p = .007, as 60% of
the SZ group, 80% of the BP+ group, and 36% of the BP- group were taking mood
stabilizers at time of testing; regarding antidepressants, chi-square (2) = 17.11, p < .001,
as 0% of the SZ group, 36% of the BP+ group, and 52% of the BP- group were taking
antidepressants at time of testing; and, regarding anti-anxiety medications, chi-square (2)
= 9.16, p = .010, as 4% of the SZ group, 32% of the BP+ group, and 8% of the BP- group
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were taking anti-anxiety medications at time of testing. There were also significant
differences for the proportion of individuals who were un-medicated at the time of
assessment, chi-square (2) = 3.03, p = .220, as 4% of the SZ group, 12% of the BP+
group, and 20% of the BP- group were not medicated at time of testing.
Given the significant differences in medication status in the groups, Spearman
correlations were used to evaluate the relationships between medication status and
neurocognitive performance (see Tables 10 and 11). The neurocognitive performance of
the NC group was not included in these analyses, as none of the NC participants were
taking psychiatric medications at time of testing. Additionally, Bonferroni corrections
were used to account for inflated Type I error rates due to multiple correlations.
Significant relationships were present between use of antipsychotics and of
antidepressants at time of testing with both non-strategy-based and strategy-based
learning and memory variables. In such cases, medication use was at times found to be
associated with better performance on the neurocognitive variables, and at other times to
be associated with worse performance on the neurocognitive variables.
Data Transformations
As previously stated, a number of the variables (specifically, CVLT Primacy,
CVLT Middle, CVLT Recency, CVLT Intrusions, CVLT Recognition False Positives,
CVLT Recall/Recognition, Biber Primacy, Biber Middle, Biber Recency, Biber
Intrusions, Biber Recognition False Positives, and Biber Recall/Recognition) were not
normally distributed, and were thus transformed into ranked data to accommodate for this
non-normality. Additionally, given that these variables made up the vast majority (i.e.,
12 of 14, or 85.71%) of those included in the second MANOVA, the remaining two
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Table 10. Spearman Correlation Coefficients between Medication Status and NonStrategy-Based Learning and Memory Variables.
CVLT Variables
Biber Variables
SD
LD
T1
Dis
SD
LD
T1
Dis
a
.31
.49**
.43** .47**
.28
.47** .41** .39**
Antipsychotic
a
.10
.17
.18
.09
.14
.22
.17
.15
Mood Stabilizer
a
-.39** -.36*
-.37*
-.25
-.29
-.34*
-.22
-.41*
Antidepressant
a
.02
.10
.13
.04
.15
.16
.13
.15
Anti-Anxiety
a
-.18
-.17
-.11
-.18
-.18
-.18
-.13
-.19
Not Medicated
Note. CVLT SD = California Verbal Learning Test. Biber = Biber Figure Learning TestType of Medication

Extended. SD = Short Delay. LD = Long Delay. T1 = Trial 1. Dis = Distractor.
a

Normal control participants were not included in these analyses.

*p < .05 (with Bonferroni correction, when p < .00625).
** p < .01 (with Bonferroni correction, when p < .00125).
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Table 11. Spearman Correlation Coefficients between Medication Status and Strategy-Based Learning and Memory Variables.
Type of
Medication
Pri

Mid

CVLT Variables
Rec
Int
RB

RFP

R/R

Pri

Mid

Biber Variables
Rec
Int
RB

RFP

R/R

Anti.33
.22 -.13
.06
.15
.19 .07
.22
.23
.01
.19 -.16
.34* .24
psychotica
Mood
.02
.10 -.14
.20 .08
-.07 -.03 .23
-.15
-.13 .20 -.08
.23
.14
Stabilizera
Anti.10 -.25
.13
-.17 -.39** -.24 -.24 .17
-.08
-.25 -.07 .05 -.21
-.22
depressanta
Anti.10 -.23
.21
.23
.15
.00 -.20
.11 .00
-.18
.02 -.03
.06
-.04
Anxietya
Not
-.16
.02
.07
-.21 -.02
-.11 -.11 -.04
.19
-.08 -.15 -.05 -.17
-.19
Medicateda
Note. CVLT = California Verbal Learning Test. Biber = Biber Figure Learning Test-Extended. Pri = % Recall Primacy Region. Mid
= % Recall Middle Region. Rec = % Recall Recency Region. Int = Free Recall Intrusions. RB = Response Bias. RFP = Recognition
False Positives. R/R = Recall/Recognition Score.
a

Normal control participants were not included in these analyses.

*p < .05 (with Bonferroni correction, when p < .00357).
**p < .01 (with Bonferroni correction, when p < .000714).
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variables – that is, CVLT and Biber Response Bias – were transformed into ranked
variables as well. However, several transformations were performed on these two
variables before they were ranked. Specifically, standard scores were derived using the
mean and standard deviation of the NC group for the two variables. Large z-scores,
whether positive or negative, were indicative of greater positive and negative response
biases, respectively. For this reason, the absolute value of the z-scores for each of the
participants was taken, so that deviations from the mean, whether positive or negative,
were equally weighted. These variables were then reverse scored so that higher scores
reflected better performance. The variables were then ranked and included in the
MANOVA.
Several other variables were also reverse scored so that higher scores reflected
better performance, including CVLT Intrusions, CVLT Recognition False Positives,
CVLT Recall/Recognition, Biber Intrusions, Biber Recognition False Positives, and
Biber Recall/Recognition. It was at this point that the variables for the second
MANOVA were converted to ranked scores. See Tables 12-15 for a comparison of
unranked and ranked scores for each of the groups, as well as Table 16 for a comparison
of the raw scores of the groups for CVLT and Biber Primacy, Middle and Recency.
Analyses of the Main Hypotheses
Following the completion of the preliminary analyses, multivariate analyses of
variance (MANOVAs) were used to test each of the three main hypotheses and to
evaluate for the presence of differences among the groups on the neurocognitive variables.
The first MANOVA was performed using the general (i.e., CVLT and Biber Short Delay
Correct and Long Delay Correct) and short-term (i.e., CVLT and Biber Trial 1 Correct
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Table 12. Unranked and Ranked Scores for the Schizophrenia Group.
Variables

Unranked
Ranked
Mean
SD
Mean
SD
CVLT % Recall Primacy Region
28.63 13.27 50.62 39.30
CVLT % Recall Middle Region
37.04 10.53 32.74 28.43
CVLT % Recall Recency Region
34.33 17.88 63.88 37.78
CVLT Intrusions
5.44
6.25 29.14 22.43
CVLT Response Bias
-0.02
0.59 25.66 21.29
CVLT Recognition False Positives
4.84
5.74 28.44 26.36
CVLT Recall/Recognition
4.68
3.15 29.28 23.29
Biber % Recall Primacy Region
35.90 19.33 57.56 38.78
Biber % Recall Middle Region
42.06 16.69 42.34 36.07
Biber % Recall Recency Region
22.04 10.93 38.30 35.39
Biber Intrusions
4.08
6.61 37.02 28.51
Biber Response Bias
0.17
0.54 48.94 38.86
Biber Recognition False Positives
8.20
7.70 22.16 18.99
Biber Recall/Recognition
4.24
4.68 27.86 26.97
Note. CVLT = California Verbal Learning Test. Biber = Biber Figure Learning TestExtended.

Table 13. Unranked and Ranked Scores for the Bipolar Disorder with Psychosis Group.
Variables

Unranked
Ranked
Mean
SD
Mean
SD
CVLT % Recall Primacy Region
29.46
5.42 55.10 27.45
CVLT % Recall Middle Region
43.42
7.58 52.42 30.38
CVLT % Recall Recency Region
27.12
4.74 48.06 25.76
CVLT Intrusions
1.12
1.54 60.76 25.95
CVLT Response Bias
-0.04
0.34 55.16 26.63
CVLT Recognition False Positives
0.76
1.27 56.98 24.72
CVLT Recall/Recognition
1.72
2.59 56.84 31.02
Biber % Recall Primacy Region
29.77
4.37 45.90 24.28
Biber % Recall Middle Region
43.18 10.09 55.74 29.29
Biber % Recall Recency Region
27.05 10.23 53.84 31.12
Biber Intrusions
0.96
1.46 51.84 25.31
Biber Response Bias
0.68
0.46 53.26 23.64
Biber Recognition False Positives
1.76
3.06 56.34 26.45
Biber Recall/Recognition
1.56
2.22 54.34 27.01
Note. CVLT = California Verbal Learning Test. Biber = Biber Figure Learning Test-

Extended.
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Table 14. Unranked and Ranked Scores for the Bipolar Disorder without Psychosis
Group.
Variables

Unranked
Ranked
Mean
SD
Mean
SD
CVLT % Recall Primacy Region
27.26
4.12 43.94 22.79
CVLT % Recall Middle Region
46.33
4.74 62.10 24.33
CVLT % Recall Recency Region
26.41
4.87 43.74 24.18
CVLT Intrusions
1.92
3.10 53.00 27.99
CVLT Response Bias
0.01
0.30 59.12 25.16
CVLT Recognition False Positives
0.84
1.28 54.08 24.53
CVLT Recall/Recognition
2.28
1.88 50.08 22.94
Biber % Recall Primacy Region
29.88
6.83 48.60 29.95
Biber % Recall Middle Region
44.06
5.48 53.40 27.26
Biber % Recall Recency Region
26.06
3.82 54.54 24.01
Biber Intrusions
0.76
1.51 56.46 23.31
Biber Response Bias
0.66
0.46 51.08 23.93
Biber Recognition False Positives
1.32
2.27 57.38 23.78
Biber Recall/Recognition
1.28
1.86 56.96 25.88
Note. CVLT = California Verbal Learning Test. Biber = Biber Figure Learning TestExtended.
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Table 15. Unranked and Ranked Scores for the Normal Control Group.
Variables

Unranked
Ranked
Mean
SD
Mean
SD
CVLT % Recall Primacy Region
27.94
4.41 52.34 24.15
CVLT % Recall Middle Region
44.69
6.75 54.74 25.62
CVLT % Recall Recency Region
27.37
5.19 46.32 23.18
CVLT Intrusions
1.76
4.01 59.10 25.38
CVLT Response Bias
-0.11
0.18 62.06 16.47
CVLT Recognition False Positives
0.32
0.48 62.50 17.85
CVLT Recall/Recognition
1.12
1.76 65.80 24.69
Biber % Recall Primacy Region
29.91
2.47 49.94 20.06
Biber % Recall Middle Region
43.75
4.79 50.52 21.51
Biber % Recall Recency Region
26.34
3.50 55.32 21.59
Biber Intrusions
0.68
1.35 56.68 22.67
Biber Response Bias
0.65
0.50 48.72 21.00
Biber Recognition False Positives
0.48
0.82 66.12 18.19
Biber Recall/Recognition
0.84
1.43 62.84 21.73
Note. CVLT = California Verbal Learning Test. Biber = Biber Figure Learning TestExtended.
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Table 16. Comparison of the Raw Scores of the Groups for CVLT and Biber Primacy,
Middle, and Recency Regions.
Variables
SZ (n=25)
Mean SD

Group
BP+ (n=25)
BP- (n=25)
Mean SD Mean SD

SZ (n=25)
Mean SD

CVLT Primacy Region
Number recalled from
2.74 15.32 2.87 16.92 3.24
8.88
5.11 15.88
Total number recalled
5.42 27.26 4.12 27.94 4.41
28.63 13.27 29.46
% Recalled from region 29.80 11.48 54.96 10.96 56.28 7.75 60.60 8.91
CVLT Middle Region
Number recalled from
7.85 26.08 4.39 27.36 6.40
11.28 5.93 24.44
Total number recalled
7.58 46.33 4.74 44.69 6.75
37.04 10.53 43.42
% Recalled from region 29.80 11.48 54.96 10.96 56.28 7.75 60.60 8.91
CVLT Recency Region
Number recalled from
9.64
4.88 14.64
2.80 14.88 3.24 16.32 2.25
Total number recalled
4.74 26.41 4.87 27.37 5.19
34.33 17.88 27.12
% Recalled from region 29.80 11.48 54.96 10.96 56.28 7.75 60.60 8.91
Biber Primacy Region
Number recalled from
9.12
5.37 15.92
3.29 15.88 3.77 17.48 2.31
Total number recalled
4.37 29.88 6.83 29.91 2.47
35.90 19.33 29.77
% Recalled from region 25.36 12.56 54.16 11.50 53.44 10.77 58.72 8.15
Biber Middle Region
Number recalled from
5.91 23.72 6.11 25.88 5.15
10.68 6.08 25.08
Total number recalled
42.06 16.69 43.18 10.09 44.06 5.48 43.75 4.79
% Recalled from region 25.36 12.56 54.16 11.50 53.44 10.77 58.72 8.15
Biber Recency Region
Number recalled from
5.56
3.70 13.16
4.03 13.84 3.02 15.36 2.23
Total number recalled
22.04 10.93 27.05 10.23 26.06 3.82 26.34 3.50
% Recalled from region 25.36 12.56 54.16 11.50 53.44 10.77 58.72 8.15
Note. SZ = Schizophrenia group. BP+ = Bipolar disorder with psychotic features group.
BP- = Bipolar disorder without psychotic features group. NC = Normal control group. SD
= Standard deviation. CVLT = California Verbal Learning Test.

and Distractor Correct) memory factors. The second MANOVA was performed using
the primacy/recency (i.e., CVLT and Biber % Recall from the Primacy, Middle, and
Recency regions) and response discrimination (i.e., CVLT and Biber Free Recall
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Intrusions, Response Bias, and Recognition False Positives) factors, as well as a derived
Recall/Recognition score, also for both the CVLT and Biber. For each of the two
MANOVAs, the neurocognitive variables served as the dependent factors, and the
diagnostic category (i.e., SZ, BP+, BP-, and NC) served as the between-subjects factor.
One-way analyses of variance (ANOVAs) were also run for all variables when the
overall MANOVA was significant, with post-hoc tests used to identify significant
between-group differences when ANOVAs yielded significant results.
For each of the two MANOVAs, analyses were initially conducted using age and
education as covariates both individually and in combination with one another, given that
significant group differences were found for these variables.
For the first MANOVA (i.e., evaluating the groups on the variables associated
with the general and short-term memory factors), neither age (F (8, 88) = 1.29, p = .258)
nor education (F (8, 88) = 0.51, p < .846) were found to be significant predictors when
used as covariates individually, nor were they found to be significant predictors when
used as covariates together (age F (8, 87) = 1.47, p = .180, education F (8, 87) = 0.69, p
= .704). Additionally, there were no significant interaction effects between diagnosis and
age (F (32, 348) = 1.10, p = .333) or diagnosis and education (F (32, 348) = 0.84, p
= .726). As a result, neither of these variables was used as a covariate in the final
evaluation of Hypothesis 1.
Similarly, for the second MANOVA (i.e., evaluating the groups on the variables
associated with the primacy/recency and response discrimination factors, as well as the
CVLT and Biber Recall/Recognition scores), neither age (F (14, 82) = 1.37, p = .187) nor
education (F (14,82) = 0.63, p =.835) were found to be significant predictors when used
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individually as covariates, nor were they found to be significant predictors when used as
covariates together (age F (14, 81) = 1.53, p = .118, education F (14, 81) = 0.78, p
= .686). Additionally, there were no significant interaction effects between diagnosis and
age (F (56, 324) = 1.26, p = .111) or diagnosis and education (F (56,324) = 1.11, p
= .286). As a result, neither of these variables was used as a covariate in the final
evaluation of Hypothesis 2.
Although there were also significant differences between groups for premorbid (F
(3, 96) = 38.47, p < .001) and current (F (3, 96) = 21.21), p < .001) IQ estimates, some
researchers have argued that such differences, specifically that individuals with severe
mental illness have significantly lower premorbid and current IQ estimates than do
unaffected individuals, are characteristics of the disorders themselves, and thus should
not be covaried out of statistical analyses when comparing these groups to one another
and to unaffected individuals (Dennis et al., 2009). For this reason, neither premorbid
nor current IQ was included in the analyses as a covariate.
Given the significant relationships identified between symptomatology at time of
testing and neurocognitive performance across a number of the non-strategy-based and
strategy-based learning and memory variables, symptomatology ratings were also
considered as covariates for the two MANOVAs. Specifically, the significant
relationships noted between the neurocognitive variables and the Thought Disturbance,
Anergia, and Disorganization factors of the Brief Psychiatric Rating Scale suggested a
potential influence of these factors on neurocognitive performance. A variable was
therefore computed as the sum of these factor scores for each participant (including NCs)
and was included as a covariate in each of the MANOVAs. This variable was not a

93

significant predictor when used as a covariate for either of the MANOVAs (first
MANOVA F (8, 84) = 1.32, p = .245, second MANOVA F (14, 78) = 1.19, p = .301).
This variable was therefore not included as a covariate in the final analyses of either of
the hypotheses.
Box’s Test of Equality of Covariance Matrices was computed to examine whether
the assumption of normality of variance-covariance had been met for each of the two
MANOVAs. Box’s M was not significant for the first MANOVA, Box’s M = 124.05, F
= 0.98, p = .555. Conversely, Box’s M was significant for the second MANOVA, Box’s
M = 700.04, F = 1.63, p < .001. Pillai’s trace was thus used to calculate F (Tabachnick &
Fidell, 2001) for both MANOVAs.
Hypothesis 1: Across all memory scores, degradation in learning and memory will be
present across all groups based on severity of psychosis, so that the NC group will
exhibit normal performance, with the BP- group exhibiting the least severe deficits,
followed by the BP+, and finally the SZ group, which will have the worst performance.
These differences between groups will be statistically significant (p < .05).
To evaluate Hypothesis 1, a MANOVA was computed using the general (i.e.,
Short Delay Correct and Long Delay Correct) and short-term (i.e., Trial 1 Correct and
Distractor Correct) factor variables for both the CVLT and the Biber. Results indicated a
significant difference among the groups, F (3, 96) = 4.05, p < .001 (see Table 17).
Given the statistical significance of the overall MANOVA, individual ANOVAs
and subsequent post-hoc tests were used to identify group differences for each of the
neurocognitive variables (see Table 18, as well as Figures 3 and 4). These analyses
indicated that the SZ group performed significantly worse than the BP+, BP-, and NC
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Table 17. Results of the MANOVAs.
F
General Memory and
Short-term Memory Factors
Primacy/Recency and
Response Discrimination Factors,
and Recall/Recognition Scores

p

4.05

<.001

2.25

<.001
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Table 18. Neurocognitive Performance of the Groups on Non-Strategy-Based Learning and Memory Variables.
Variables
SZ (n=25)

SD
Mean
3.50 12.04

SD
Mean
2.87 12.08

NC (n=25)

SD
Mean
1.91 12.60

SD
2.69

F
p
37.94 <.001

Effect Sizec
BP+ vs. BP+ vs. BP- vs.
BPNC
NC
d
d
d

Scheffé
SZ < BP+,
BP-, NC
5.16
3.44 12.04
2.91 12.24
1.92 13.00
2.53 44.03 <.001
0.2
0.2
SZ < BP+,
BP-, NC
1.71
7.20
2.29
6.96
1.46
8.40
1.80 23.28 <.001
0.3
0.4
SZ < BP-,
4.20
BP+, NC
3.84
1.82
6.80
2.02
7.28
2.07
8.24
2.33 21.02 <.001
0.3
0.2
SZ < BP+,
BP-, NC
14.60 11.24 33.56
8.47 33.16
6.76 36.32
7.34 33.43 <.001
0.2
0.2
SZ < BP-,
BP+, NC
Biber LDa 14.44 10.78 34.76
8.66 35.48
7.45 38.32
7.27 40.30 <.001
0.2
0.2
SZ < BP+,
BP-, NC
Biber T1b
9.04
6.71 17.40
6.49 16.52
5.89 20.28
6.54 13.94 <.001
0.2
0.3
SZ < BP-,
BP+, NC
4.29 15.96
6.84 15.84
7.99 17.96
6.15 21.68 <.001
0.2
SZ < BP-,
Biber
4.72
BP+, NC
Disb
Note. SZ = Schizophrenia group. BP+ = Bipolar disorder with psychotic features group. BP- = Bipolar disorder without psychotic
CVLT
SDa
CVLT
LDa
CVLT
T1b
CVLT
Disb
Biber SDa

Mean
5.36

Group
BP+ (n=25)
BP- (n=25)

features group. NC = Normal control group. SD = Standard deviation. CVLT SD = California Verbal Learning Test Short Delay.
CVLT LD = California Verbal Learning Test Long Delay. CVLT T1 = California Verbal Learning Test Trial 1. CVLT Dis =
California Verbal Learning Test Distractor. Biber SD = Biber Figure Learning Test-Extended Short Delay. Biber LD = Biber Figure
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Learning Test-Extended Long Delay. Biber T1 = Biber Figure Learning Test-Extended Trial 1. Biber Dis = Biber Figure Learning
Test-Extended Distractor.
a

General Memory Factor. bShort-term Memory Factor. cOnly effect sizes which were 0.2 or greater are reported.
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Figure 3. Non-Strategy-Based Verbal Learning and Memory Performance of the Groups
as Measured by the California Verbal Learning Test.
0

-1
Standard Scores

Sz
BP+
-2
BPNC
-3

-4
SD

LD

T1

Dis

Non-Strategy-Based Verbal Learning and Memory Variables

Note. Sz = Schizophrenia group. BP+ = Bipolar disorder with psychotic features group.
BP- = Bipolar disorder without psychotic features group. NC = Normal control group. SD
= California Verbal Learning Test Short Delay. LD = California Verbal Learning Test
Long Delay. T1 = California Verbal Learning Test Trial 1. Dis = California Verbal
Learning Test Distractor.
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Figure 4. Non-Strategy-Based Visual Learning and Memory Performance of the Groups
as Measured by the Biber Figure Learning Test-Extended.

0

Standard Scores

-1
Sz
BP+
-2
BPNC
-3

-4

SD

LD

T1

Dis

Non-Strategy-Based Visual Learning and Memory Variables

Note. Sz = Schizophrenia group. BP+ = Bipolar disorder with psychotic features group.
BP- = Bipolar disorder without psychotic features group. NC = Normal control group. SD
= Biber Figure Learning Test-Extended Short Delay. LD = Biber Figure Learning TestExtended Long Delay. T1 = Biber Figure Learning Test-Extended Trial 1. Dis = Biber
Figure Learning Test-Extended Distractor.
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groups on all measures of general and short-term memory. No significant differences
were present, however, between the BP+, BP-, or NC groups on any of these variables.
This is consistent with the expectation that the SZ group would perform worse than all
other groups on these variables, but inconsistent with the hypothesis that the BP+ and
BP- groups would perform significantly better than the SZ group, but significantly worse
than the NC group. However, there were notable effect sizes, albeit small, for a number
of the variables (see Table 18).

Hypothesis 2: In addition to a degradation in memory performance across the clinical
groups, the BP- group will exhibit relative sparing of ability on memory test scores that
reflect strategy-based deficiencies in learning (e.g., semantic clustering) and retrieval
(e.g., normal recall vs. recognition discrepancies), and will not differ from the NC group
on these measures. However, the psychosis groups will perform significantly worse (p
< .05) than the BP- and NC groups on these measures.
To evaluate Hypothesis 2, a MANOVA was computed using the primacy/recency
(i.e., % Recall from the Primacy, Middle, and Recency regions) and response
discrimination (i.e., Intrusions, Response Bias, and Recognition False Positives) factors
for both the CVLT and the Biber, as well as derived Recall/Recognition scores for both
measures. Results indicated a significant difference among the groups, F (3, 96) = 2.25,
p < .001 (see Table 17). Given the statistical significance of the overall MANOVA,
individual ANOVAs and, when relevant, subsequent post-hoc tests were used to identify
group differences for each of the neurocognitive variables (see Table 19, as well as
Figures 5 and 6).
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Table 19. Neurocognitive Performance of the Groups on Strategy-Based Learning and Memory Variables.
Variables
SZ (n=25)

Group
BP+ (n=25)
BP- (n=25)

NC (n=25)

CVLT Pria, b
CVLT Mida, b
CVLT Reca, b
CVLT Intb, c, e

Mean
50.62
32.74
63.88
29.14

SD
39.30
28.43
37.78
22.43

Mean
55.10
52.42
48.06
60.76

SD
27.45
30.38
25.76
25.95

Mean
43.94
62.10
43.74
53.00

SD
22.79
24.33
24.18
27.99

Mean
52.34
54.74
46.32
59.10

SD
24.15
25.62
23.18
25.38

F
0.66
5.23
2.57
8.21

p
.577
.002
.058
<.001

CVLT RBb, c, d, e

25.66

21.29

55.16

26.63

59.12

25.16

62.06

16.47

13.66

<.001

CVLT RFPb, c, e
CVLT R/Rb, c
Biber Pria, b
Biber Mida, b
Biber Reca, b
Biber Intb, c, e
Biber RBb, c, d, e
Biber RFPb, c, e

28.44
29.28
57.56
42.34
38.30
37.02
48.94
22.16

26.36
23.29
38.78
36.07
35.39
28.51
38.86
18.99

56.98
56.84
45.90
55.74
53.84
51.84
53.26
56.34

24.72
31.02
24.28
29.29
31.12
25.31
23.64
26.45

54.08
50.08
48.60
53.40
54.54
56.46
51.08
57.38

24.53
22.94
29.95
27.26
24.01
23.31
23.93
23.78

62.50
65.80
49.94
50.52
55.32
56.68
48.72
66.12

17.85
24.69
20.06
21.51
21.59
22.67
21.00
18.19

10.26
9.15
0.74
1.02
2.04
3.41
0.15
19.22

<.001
<.001
.533
.390
.114
.021
.932
<.001

Biber R/Rb, c

27.86

26.97

54.34

27.01

56.96

25.88

62.84

21.73

9.25

<.001

Effect Sizeg
BP+
BP+
BPvs. BP- vs. NC vs. NC
d
D
d
0.2
0.2
0.2

0.2

0.2

0.2
0.3

0.2

0.2

0.2

Scheffé
SZ < NC, BPSZ < BP-,
NC, BP+
SZ < BP+,
BP-, NC
SZ < BP-, BP+, NC
SZ < BP-, BP+, NC

SZ < BP+,
BP-, NC
SZ < BP+,
BP-, NC

Note. SZ = Schizophrenia group. BP+ = Bipolar disorder with psychotic features group. BP- = Bipolar disorder without psychosis
group. NC = Normal control group. SD = Standard deviation. CVLT Pri = California Verbal Learning Test % Recall Primacy Region.
CVLT Mid = California Verbal Learning Test % Recall Middle Region. CVLT Rec = California Verbal Learning Test % Recall
Recency Region. CVLT Int = California Verbal Learning Test Free Recall Intrusions. CVLT RB = California Verbal Learning Test
Response Bias. CVLT RFP = California Verbal Learning Test Recognition False Positives. CVLT R/R = California Verbal Learning
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Test Recall/Recognition Score. Biber Pri = Biber Figure Learning Test-Extended % Recall Primacy Region. Biber Mid = Biber Figure
Learning Test-Extended % Recall Middle Region. Biber Rec = Biber Figure Learning Test-Extended % Recall Recency Region. Biber
Int = Biber Figure Learning Test-Extended Free Recall Intrusions. Biber RB = Biber Figure Learning Test-Extended Response Bias.
Biber RFP = Biber Figure Learning Test-Extended Recognition False Positives. Biber R/R = Biber Figure Learning Test-Extended
Recall/Recognition Score.
a

Primacy/Recency Factor. bRanked data used. cReverse scored. dDerived standard score used. eResponse Discrimination Factor. fn=24.

g

Only effect sizes which were 0.2 or greater are reported.
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Figure 5. Strategy-Based Verbal Learning and Memory Performance of the Groups as
Measured by the California Verbal Learning Test.
2

Standard Scores

1

Sz

0

BP+
BP-1

NC

-2

-3

Pri

Mid

Rec

Int

RB

RFP

R/R

Strategy-Based Verbal Learning and Memory Variables

Note. Sz = Schizophrenia group. BP+ = Bipolar disorder with psychotic features group.
BP- = Bipolar disorder without psychotic features group. NC = Normal control group. Pri
= California Verbal Learning Test % Recall Primacy Region. Mid = California Verbal
Learning Test % Recall Middle Region. Rec = California Verbal Learning Test % Recall
Recency Region. Int = California Verbal Learning Test Free Recall Intrusions. RB =
California Verbal Learning Test Response Bias. RFP = California Verbal Learning Test
Recognition False Positives. R/R = California Verbal Learning Test Recall/Recognition
Score.
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Figure 6. Strategy-Based Visual Learning and Memory Performance of the Groups as
Measured by the Biber Figure Learning Test-Extended.
1

Standard Scores

0
Sz
BP+
-1
BPNC
-2

-3

Pri

Mid

Rec

Int

RB

RFP

R/R

Strategy-Based Visual Learning and Memory Variables

Note. Sz = Schizophrenia group. BP+ = Bipolar disorder with psychotic features group.
BP- = Bipolar disorder without psychotic features group. NC = Normal control group. Pri
= Biber Figure Learning Test-Extended % Recall Primacy Region. Mid = Biber Figure
Learning Test-Extended % Recall Middle Region. Rec = Biber Figure Learning TestExtended % Recall Recency Region. Int = Biber Figure Learning Test-Extended Free
Recall Intrusions. RB = Biber Figure Learning Test-Extended Response Bias. RFP =
Biber Figure Learning Test-Extended Recognition False Positives. R/R = Biber Figure
Learning Test-Extended Recall/Recognition Score.
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Post-hoc tests demonstrated that, within the primacy/recency factor, the SZ group
remembered significantly fewer words from the middle portion of the CVLT word list
than did the NC and BP- groups, and that the SZ group remembered fewer images from
the primacy, middle, and recency portions of the series of figures from the Biber than did
the BP+, BP-, and NC groups. Post-hoc tests computed for the response discrimination
factor variables indicated that the SZ group had significantly more intrusions on the
CVLT, greater CVLT Response Bias, and had significantly more false positives on the
recognition portions of both the CVLT and the Biber as compared to the BP+, BP-, and
NC groups. Finally, post-hoc analyses of the computed recall/recognition scores
indicated that the difference between the number of words and images remembered when
presented via the recognition tasks and when the participants were asked to remember the
words and images independent of cues was significantly greater for the SZ group than the
BP+, BP-, and NC groups for both the CVLT and the Biber, suggesting that the SZ group
had greater retrieval difficulties than did any of the other groups. Overall, these findings
generally support the hypothesis that the SZ group would perform worse than the BP+,
BP-, and NC groups on strategy-based learning and memory variables. However, these
findings do not support the hypothesis that the BP+ group would perform better than the
SZ group, but worse than the BP- and NC groups, or the hypothesis that the BP- and NC
groups would perform similar to one another. However, as with the first MANOVA,
there were notable effect sizes, albeit small, for a number of the variables (see Table 19).
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Hypothesis 3: No specific hypotheses will be made regarding the interaction between
lateralization effects in BP with or without psychosis given the current lack of
information in this area. However, given that visual working memory deficits have been
suggested as an endophenotype for psychosis and that the findings regarding differential
hemispheric involvement in BP have been mixed, it is hypothesized that visual memory
performance will be relatively preserved in the BP- group and impaired in the BP+
group.
Finally, Hypothesis 3 was evaluated by comparing the performance of the BP+,
BP-, and NC groups on the visual learning and memory variables from both MANOVAs.
Contrary to what was expected, there were no significant differences among these groups
on any of the visual learning and memory variables (see Tables 18 and 19, as well as
Figures 4 and 6).
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CHAPTER 5
DISCUSSION
The presence of neurocognitive deficits has been documented extensively in
individuals with psychiatric disorders, including bipolar disorder and schizophrenia.
Findings regarding such deficits, however, have been mixed across studies. One
hypothesis regarding such mixed findings has been that a subset of neurocognitive
deficits may successfully differentiate between psychiatric patients with and without
concomitant psychotic features. Such deficits may thus be endophenotypic markers of
psychosis, rather than an indicator of a particular diagnosis (e.g., SZ vs. BP), leading to
the hypothesis that some neurocognitive deficits could potentially be used to identify
individuals at-risk for psychosis. This study attempted to demonstrate that
neurocognitive performance across a number of strategy-based learning and memory
variables would differentiate between groups of individuals with and without psychotic
features. In other words, this research explored the idea that schizophrenia and bipolar
disorder are related disorders, rather than separate disorders as defined in the current
nosological framework outlined by the DSM-IV (APA, 1994).
Based on these considerations, the purpose of this study was to examine the
presence and, when applicable, severity of verbal and visual learning and memory
deficits in individuals with bipolar disorder with (BP+) and without (BP-) psychosis. A
secondary purpose of this study was to determine whether these neurocognitive domains
were also impaired in a group of individuals with schizophrenia (SZ). A normal control
group (NC) was included for purposes of comparison. Results were expected to indicate
deficits in general and short-term verbal and visual learning and memory in all
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psychiatric groups, with the most severe deficits anticipated to be found in the SZ group,
followed by the BP+ and BP- groups, who were expected to perform similar to one
another on these variables. Furthermore, a continuum of severity of deficits was
expected to be exhibited across a number of verbal and visual learning and memory
variables thought to be dependent on strategy-based learning, with the SZ group
demonstrating the most severe deficits, followed by the BP+ group. The BP- group was
expected to perform similar to the NC group on these variables. In this manner, learning
and memory variables tapping into strategy-based learning were expected to differentiate
between individuals with psychiatric disorders with (i.e., SZ and BP+) and without (i.e.,
BP-) co-occurring psychotic features.
Findings regarding the first hypothesis, namely that the NC group would perform
better than the BP- and BP+ groups, who would in turn perform better than the SZ group,
on measures of general and short-term memory were mixed. In partial support of this
hypothesis, the SZ group did perform significantly worse than all other groups across all
general and short-term memory variables. However, there were no significant
differences in group performance among the BP+, BP-, and NC groups on any of these
variables. Qualitatively speaking, the expected continuum of performance (i.e., SZ <
BP+, BP- < NC) was evident, although not statistically significant, for all of the variables
included in the general and short-term memory factors. Thus, the expected trend did
occur, although the differences between the BP and NC groups were not great enough to
allow for statistical significance. However, as previously mentioned there were notable
effect sizes, albeit small, for a number of variables (see Table 18). It is possible,
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therefore, that significant differences between these groups may have been evident with
more power, for example if more participants had been included in the study.
The second hypothesis, in which the NC and BP- groups, and likewise the BP+
and SZ groups, were expected to perform similar to one another on variables of verbal
and visual learning and memory thought to reflect strategy-based learning, also yielded
mixed results. In partial support of our hypothesis, the SZ group did perform
significantly worse than both the NC and BP- groups across many of these variables,
while the BP- and NC groups performed similar to one another as expected. However,
the BP+ did not demonstrate significant impairments similar to those of the SZ group as
expected. Instead, the performance of the BP+ group was found to resemble that of the
NC and BP- groups. As with the first hypothesis, performance across groups on the
strategy-based learning and memory variables indicated a general trend in the expected
direction (i.e., SZ, BP+ < BP-, NC) for three of these variables, although differences
among the BP+, BP-, and NC groups were not statistically significant. However, for the
other three variables in which there was a significant group difference overall, the SZ was
found to be more impaired than the other three groups as expected, but the BPdemonstrated poorer performance on the tasks than the BP+ group, with the NC group
having performed best (i.e., SZ < BP- < BP+ < NC). Yet as with Hypothesis 1, there
were notable effect sizes, albeit small, for a number of variables (see Table 19). It is
possible, therefore, that significant differences between these groups may have been
evident with more power, for example if more participants had been included in the study.
Finally, our third hypothesis, namely that the BP+ group would perform
significantly worse than the BP- group across all visual learning and memory variables,
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was not substantiated. Qualitatively speaking, the BP+ group demonstrated poorer
performance on several visual learning and memory variables, while the BP- group
performed worse on others, although none of these differences was statistically
significant.
Our findings are concordant with a handful of research which has also yielded
unexpected findings regarding verbal learning and memory performance in individuals
with BP. For example, van Gorp, Altshuler, Theberge, Wilkins and Dixon (1998) found
that a BP with lifetime alcohol dependence group demonstrated significant impairment as
compared to normal controls across a number of verbal learning and memory variables.
However, a BP without lifetime alcohol dependence group demonstrated significantly
lower performance on some (i.e., CVLT Trials 1-5 Correct, Short Delay Cued Recall, and
Long Delay Cued Recall), but not all (i.e., CVLT Short Delay Free Recall and Long
Delay Free Recall) verbal learning and memory variables. Impairment in short- and
long-delay free recall of verbal information may thus be associated with factors other
than bipolar disorder itself, such as previous substance dependence. If this is the case,
then previous findings of verbal learning and memory impairment may have actually
been reflections of comorbid substance dependence, rather than of impairments due to
bipolar disorder itself. In consideration of this hypothesis, we compared the
neurocognitive performance of psychiatric participants with and without a history of
alcohol or substance abuse or dependence via two MANOVAs and found no significant
differences between the groups in overall neurocognitive performance for either nonstrategy-based (F (8, 66) = 1.10, p = .374) or strategy-based (F (14, 60) = 0.84, p = .627)
learning and memory (see Table 20). It can therefore be assumed that the presence of a
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significant substance use history likely had a minimal effect on neurocognitive
impairment outside of the psychiatric diagnoses themselves. Additionally, a post-hoc
chi-square analysis indicated no significant difference in the proportion of participants
with a previous diagnosis of substance or alcohol abuse or dependence in the psychiatric
groups (chi-square (2) = 1.71, p = .424), suggesting that any negative effect of a history
of such diagnoses on neurocognitive function was spread equally among the groups.

Table 20. Results of the MANOVAs Comparing the Neurocognitive Performance of the
Previous Substance Use Diagnosis and No Previous Substance Use Diagnosis Groups on
Non-Strategy-Based and Strategy-Based Learning and Memory Variables.

Non-strategy-based learning and
memory variables
Strategy-based learning and memory
variables

F

p

1.10

.374

0.84

.627

Other research has found evidence of verbal learning and memory impairment in
individuals diagnosed with BP to be present only when variables such as age and
education have not been used as covariates in the model. Ferrier, Stanton, Kelly, and
Scott (1999), for example, compared a group of individuals with BP with no distinctions
made between bipolar I disorder and bipolar II disorder, nor between bipolar disorder
with and without psychotic features to a group of normal controls. Initial statistical
analyses revealed evidence of impairments in both verbal and nonverbal (i.e., visual)
learning and memory in the BP group. However, once the analyses were re-run using age,
premorbid intelligence, and current depressive symptoms (as measured by the Hamilton
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Depression Rating Scale) as covariates, these differences in learning and memory
performance were no longer statistically significant for both verbal and visual learning
and memory. Upon examination of the study procedures, it is understandable that HDRS
scores were used as a covariate, given that there was a statistically significant difference
in the degree of depressive symptomatology noted in the BP and normal control groups.
However, the authors reported that there were no significant between-group differences
with regards to either age or premorbid intelligence. It is therefore unclear why these two
variables were included as covariates, other than perhaps due to the traditional use of
these variables as covariates within this research area. Nevertheless, the inclusion of
such variables as coviariates may result in the perhaps erroneous covarying out of effects
of the disorders themselves, an argument which has been previously mentioned (Dennis
et al., 2009). Given that no variables such were included as covariates in our own
research, our findings are concordant with those of Ferrier and colleagues.
Finally, our findings are also somewhat in agreement with research comparing
individuals with bipolar disorder with and without psychotic features that have not
identified significant group differences on measures of verbal learning and memory. For
example, Glahn and colleagues’ (2007) evaluation of individuals with bipolar I disorder
with and without psychosis found some, but not all, measure of verbal learning and
memory to differentiate between the groups, despite significant impairment of both
groups on all measures of verbal learning and memory as compared to a normal control
group. However, Glahn and colleagues included a sample whose characteristics were
more convoluted than that of our own. Specifically, the participants in Glahn and
colleagues’ research included individuals who were euthymic, depressed, and manic at

112

time of testing, as well as a large number (specifically, 69% of the participants) of
individuals who had a comorbid diagnosis for premorbid substance abuse (as compared
to 47% of all psychiatric participants, and 52% of the BP participants, in our own
sample). It may therefore be that the presence of such deficits in these populations is
reflective of mood state and/or a comorbid substance use diagnosis, rather than to the
nature of the psychotic features themselves.
Bora and colleagues (2007) also found no evidence of differential verbal learning
and memory impairment according to the presence or absence of psychosis in individuals
with BP. However, they did identify significant verbal learning and memory impairment
in the BP+ group as compared to the NC group, a finding which is discordant with our
own.
The inability of verbal learning and memory level of performance to differentiate
between the BP+ and BP- groups in this study is thus in agreement with the findings of a
number of other researchers.
In contrast, our failure to find evidence of significant verbal learning and memory
deficits in the BP groups compared to the NC group is surprising given a number of
previous research studies which have reported such findings (e.g., Atre-Vaidya et al.,
1998; van Gorp, Altshuler, Theberge, Wilkins, & Dixon, 1998; van Gorp, Altshuler,
Theberge, & Mintz, 1999; Altshuler et al., 2004; Martínez-Arán, Vieta, Colom et al.,
2004; Thompson et al., 2005; Robinson et al., 2006; Martínez-Arán et al., 2007; Martino
et al., 2008).
Zubieta, Huguelet, O’Neil, and Giordani (2001), for example, found evidence of
neurocognitive impairment in a group of individuals diagnosed with BP with psychotic
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features in the domains of executive functioning, verbal fluency, attention and
concentration, and psychomotor speed. The BP group was also found to have exhibited
significant verbal learning and memory deficits as compared to the normal control group
in the domain of verbal learning and memory, albeit only on tasks requiring learning and
memory of word lists, and not on tasks requiring learning and memory of verbally
administered passages, thus suggesting a deficit in the organizational strategy component
of memory.
Martínez-Arán and colleagues (2004) reported similar findings, in that individuals
with bipolar disorder, whether depressed, manic, or euthymic at time of testing, were
found to demonstrate significantly impaired performance in the domain of verbal learning
and memory compared to the NC comparison group as measured by the CVLT, although
no comparisons were made between the BP+ and BP- groups. Furthermore, the verbal
learning and memory impairments were found to be significantly more severely impaired
than were other noted neurocognitive impairments, especially in executive functioning,
attention and concentration, and verbal fluency. Overall, these findings are obviously
discordant with our own, in that we failed to find evidence of impaired verbal learning
and memory in either of our BP groups as compared to our NC group. It is unclear,
however, whether there was differential impairment according to the presence or absence
of psychosis, as no comparisons were made between these groups. It is also unclear
whether there were differences according to mood state, as individuals in current
episodes were included in addition to euthymic individuals, with no comparisons made
between these subgroups. Such studies reporting memory deficits in non-remitted
patients, whether depressed or manic at time of testing, may simply reflect state
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neurocognitive impairment due to symptomatology, rather than to characteristics of the
disorder per se. This hypothesis is in agreement with our failure to find significant
correlations between ratings of affect at time of testing and neurocognitive performance;
given that all participants were euthymic, no relationship with neurocognitive
performance was evident.
Regarding our failure to find evidence of significant group differences on
measures of nonverbal (i.e., visual) learning and memory, our findings are in agreement
with those of several other studies. For example, as previously mentioned, Ferrier,
Stanton, Kelly, and Scott (1999) reported evidence of visual learning and memory
deficits in a group of euthymic and non-euthymic individuals diagnosed with bipolar
disorder, some with a history of psychosis and some without, as compared to a group of
normal controls. However, these differences were no longer significant once age,
premorbid intelligence, and current depressive symptomatology were included as
covariates in the analysis. Given that the ratings of depressive symptomatology at time
of testing were the only of these covariates to have been significantly different between
the BP and NC groups, these result suggest that the differences in visual learning and
memory performance may have been accounted for by the significantly greater symptoms
of depression in the BP group as compared to the NC group. If this is the case, then we
could again hypothesize that the initial findings of significantly impaired visual learning
and memory in the BP group were present due to the presence of individuals in a current
depressed episode at the time of testing, and would not have been evident had only
individuals in a current state of euthymia been included, thus potentially providing
support for our own findings.
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Our findings of no significant impairment in the neurocognitive domain of visual
learning and memory in the BP groups are also in agreement with research conducted by
Zubieta, Huguelet, O’Neil, and Giordani (2001), as well as Martínez-Arán, Vieta,
Reinares, and colleagues (2004), both of whom evaluated individuals diagnosed with
bipolar disorder who were in a euthymic state at the time of testing. Martínez-Arán,
Vieta, Reinares, and colleagues (2004) also included individuals who were in depressed
and manic episodes at time of testing, and included individuals both with and without a
history of psychosis, although they were not separated out for purposes of comparison or
data analysis. Neither study found evidence of visual learning and memory deficits in the
euthymic individuals with BP as compared to normal controls, although Martínez-Arán,
Vieta, Reinares, and colleagues did identify deficits in immediate and delayed recall for
visual information in the depressed BP group, and in delayed recall for visual information
in the manic BP group. Altogether, these results are in agreement with our own in that
visual learning and memory impairments were not noted in individuals with BP who
were euthymic at the time of testing. It may be that previous research has failed to
separate out participants in mood episodes prior to data analysis, and that visual learning
and memory impairments are only present during mood episodes and do not persist
during periods of euthymia, and thus may not serve as endophenotypic markers of
psychosis outside of mood episodes. We may have found differences, therefore, had we
evaluated participants who were in a mood episode, and thus actively psychotic in the
BP+ group, at time of testing.
A handful of studies have also reported evidence of visual learning and memory
deficits in individuals with BP (e.g., Glahn, Barrett et al., 2006; Frantom, Allen, & Cross,
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2008), also in contrast to our own findings. Such findings have also been reported in a
review conducted by Arts, Jabben, Krabbendam and van Os (2008), who reported
evidence of visual learning and memory impairments in euthymic individuals diagnosed
with BP.
In contrast to the unexpected nature of our results regarding the bipolar disorder
groups, our findings of verbal learning and memory impairment in the schizophrenia
group are in agreement with multiple accounts of such deficits in these individuals,
independent of the subtype of the disorder (e.g., Brazo et al., 2002; Brickman et al., 2004).
Riley and colleagues (2000), for example, found significant deficits in individuals with
first-episode schizophrenia, schizophreniform disorder, or schizoaffective disorder as
compared to the normal controls on some (i.e., CVLT Trials 1-5), but not all (i.e., CVLT
Long Delay Free Recall) measures of verbal learning and memory, as well as on delayed,
but not immediate, nonverbal (i.e., visual) learning and memory. Our SZ group, in
contrast, was found to demonstrate impairments on both immediate and delayed measures
of verbal and visual learning and memory, but was a group of only SZ participants and
may thus have been a more pure sample than was that of Riley and colleagues.
Furthermore, Brewer and colleagues (2006) conducted a review of studies which
had evaluated the neuropsychological performance of individuals who were deemed “atrisk” for psychosis and determined impairments in olfactory perception and spatial
working memory to be vulnerability markers for psychosis. Verbal memory, on the other
hand, was not identified as a consistent marker for later development of psychosis.
Conversely, Lencz and colleagues (2006) assessed individuals who were demonstrating
symptoms which were later determined to have been prodromal symptoms in the onset of
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schizophrenia. Upon comparison of individuals who went on to develop psychotic
symptoms within the disorder and those who did not, the psychosis participants were
found to have demonstrated significantly greater impairment within the verbal learning
and memory domain as compared to the non-psychosis participants during the prodromal
phase, suggesting that verbal learning and memory impairments may be markers of
psychotic features in individuals with schizophrenia. Thus, while our findings are in
agreement with some research and in disagreement with other research regarding the
identification of verbal learning and memory deficits, our findings fall in line with the
“mixed results” nature of investigations into this research idea thus far.
In consideration of this idea, Depp and colleagues (2007) found evidence of a
spectrum of verbal learning and memory impairment in a group of psychiatric and nonpsychiatric patients, with schizophrenia participants demonstrating the most severe
impairment, followed by individuals with bipolar disorder, compared to normal controls.
Despite this continuum in performance, however, current positive symptoms were found
to not correlate significantly with verbal memory scores. This suggests that, while
greater impairment may be expected in individuals with schizophrenia, followed by
individuals with bipolar disorder, this continuum of severity in verbal learning and
memory impairment may not be due to psychotic symptoms per se, but may be due to
some other characteristics of the disorders. In other words, verbal learning and memory
performance may not be the discriminating factor for which we are searching, especially
given the significant negative relationships found in our sample between increased
prevalence and severity of negative symptoms and decreased neurocognitive performance.

118

Finally, our findings are in disagreement with those of Albus and colleagues
(1996), who found evidence of a spectrum of disorders. When psychiatric patients were
compared according to the presence or absence of psychotic features, the affective
disorders with psychosis group performed similarly to the schizophrenia participants,
while the affective disorders without psychosis group performed similarly to the normal
controls in the neurocognitive domains of visual motor processing, attention, and verbal
learning and memory. These findings are thus in support of the spectrum hypothesis, and
thus in contrast to our own, in that we did not find evidence of such differences as
evidence of a spectrum of disorders.
Overall, the fact that our research failed to identify verbal and learning memory
impairments in a group of individuals diagnosed with bipolar disorder is surprising and
somewhat puzzling, especially given our relatively large sample size and the purported
sensitivity of the CVLT to verbal learning and memory impairments (Delis, Kramer,
Kaplan, & Ober, 2000). Additionally, the lack of differences in verbal and visual
learning and memory according to the presence or absence of psychotic features was
unexpected.
One potential reason for these unexpected findings is the method of recruitment
used throughout the study. As previously mentioned, recruitment efforts focused on
referrals from local physicians and mental health agencies, fliers posted on local
campuses and around the community, advertisements posted in press releases and listserv
e-mails, as well as advertisements at local support group meetings. Furthermore, while
there were a number of individuals with bipolar disorder who were recruited from the
community (e.g., via Craig’s List, announcements made at local bipolar disorder support
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group meetings, etc.), the academic campuses of University of Nevada Las Vegas and
College of Southern Nevada (formerly Community College of Southern Nevada) were
heavily targeted and turned out to be especially fruitful areas to find research participants.
Many normal controls were also recruited from these areas. In fact, 80% of the BP+
group, 72% of the BP- group, and 84% of the NC group had at least some education past
high school, while only 36% of the SZ group had a greater than high school education.
It is thus possible that, by relying on these locations so heavily for recruitment,
our sample became a reflection of a subset of the bipolar disorder population that was
generally higher functioning than the typical individual with bipolar disorder, and
particularly those who might be recruited from out-patient community mental health
facilities, where BP may be more severe and associated with higher levels of disability.
Specifically, one study reported that approximately 60% of individuals with bipolar
disorder enter college (Glahn, Bearden, Bowden, & Soares, 2006), a figure which is
lower than that of our own, in that 76% of the BP+ and BP- participants in the current
study completed at least one year of college. In other words, those with bipolar disorder
who are high functioning, intelligent and motivated enough to attend college and/or
community college may be qualitatively different than those without such qualities,
including in the neurocognitive domains of verbal and visual learning and memory.
Additionally, the vast majority of the SZ participants were recruited from a community
mental health facility (intensive case management) which is a resource for individuals
with severe mental illness to receive counseling, access to appropriate psychiatric
consultation and treatment, and community support. Individuals who participate in this
treatment program are generally lower functioning and more severely impaired than are
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those who are able to function on a day-to-day basis without needing to utilize such a
resource. These differences in functional impairment may have been compounded by the
fact that a greater proportion of the SZ participants (specifically, 84%) were unmedicated
at time of testing as compared to the BP+ (12%) and BP- (20%) groups. The disparity in
impairment – psychological, neurocognitive, social, occupational, intellectual, etc. –
between the SZ and BP groups, not to mention the NC group, may have therefore been
even greater than what is typical in the research setting.
The average Global Assessment of Functioning (GAF; APA, 1994) ratings for the
groups, however, suggest differences in overall functioning. Specifically, the average
GAF scores for the groups were as following: 32.81 for the SZ group, suggesting “some
impairment in reality testing or communication or major impairment in several areas,
such as work or school, family relations, judgment, thinking, or mood”; 56.96 for the
BP+ group, suggesting “moderate symptoms or any moderate difficulty in social,
occupational, or school functioning; 62.64 for the BP- group, suggesting “some mild
symptoms or some difficulty in social, occupational, or school functioning, but generally
functioning pretty well, has some meaningful interpersonal relationships”; and, 88.13 for
the NC group, suggesting “absent or minimal symptoms, good functioning in all areas,
interested and involved in a wide range of activities, socially effective, generally satisfied
with life, no more than everyday problems or concerns”. And yet these differences in
functioning, while notable, may not have been reflective of true differences in the
respective populations. In other words, the SZ group overall may have been lower
functioning than the typical individual with schizophrenia, and the BP and NC groups
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may have been higher functioning than the typical individual with bipolar disorder and
the typical “normal” adult, respectively.
Additionally, previous research with individuals with bipolar disorder has
demonstrated that greater neuropsychological impairments are associated with poorer
functional outcome (Denicoff et al., 1999), a finding which lends support to the
hypothesis that the relatively high-functioning nature of the BP group, both as compared
to the SZ group and potentially as compared to a “typical” individual with bipolar
disorder, may have at least partially accounted for our inability to find significant
evidence of verbal learning and memory impairment in the BP group. Bilder and
colleagues (2000) also found that verbal learning and memory impairment alone may not
be associated with greater impairment in individuals with schizophrenia, and that instead
such impairments in combination with deficits in executive functioning may be more
indicative of greater neuropsychological impairment. Taken together, these findings lend
support to the hypothesis that our inability to find deficits in verbal learning and memory
in either of the BP groups is a reflection of the relatively high functioning nature of the
participants in these groups.
Another potential reason for our findings lies in our inclusion of individuals
diagnosed with bipolar I disorder and bipolar II disorder in the BP+ and BP- groups. The
primary difference between the diagnostic criteria for the two subtypes of the disorders is
that, while a diagnosis of bipolar I disorder requires a history of at least one manic or
mixed episode, a diagnosis of bipolar II disorder necessitates a lack of manic episodes in
the individual’s history, and is instead marked by depressive and hypomanic episodes,
which are notably less severe in nature than are the traditional manic episodes. As a
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result, psychotic symptoms associated with bipolar II disorder occur less frequently and,
if present, always occur during episodes of major depression. In contrast, psychotic
symptoms are more commonly experienced by individuals suffering from bipolar I
disorder, especially during the manic phases of the illness, during which psychotic
features are present in approximately 50-68% of cases of mania within bipolar disorder
over the lifetime (Keck et al., 2003; Canuso, Bossie, Zhu, Youssef, & Dunner, 2008).
Therefore, the significantly greater percentage of individuals diagnosed with bipolar II
disorder in the BP- group (40%) as compared to the BP+ group (8%) may at least
partially account for our failure to find significant between group differences as expected.
In other words, our findings may reflect a lack of significant difference in verbal and
visual learning and memory performance in individuals with bipolar I versus bipolar II
disorder rather than in individuals with bipolar disorder with and without psychotic
features. This hypothesis is supported by the fact that a comparison of the bipolar I and
bipolar II participants on the neurocognitive variables in this study yielded significant
differences on only two variables, specifically CVLT Distractor and CVLT % Recall
Primacy Region.
Additionally, previous research has yielded mixed results concerning the nature of
symptomatology associated with deficits in verbal learning and memory. Heinrichs and
Vaz (2004), for example, found number of free recall intrusions on the CVLT to be
associated with the presence of negative symptoms in a group of 55 individuals
diagnosed with schizophrenia, with more intrusions being related to more severe negative
symptoms. Conversely, there was no relationship found between verbal learning and
memory performance as measured by the CVLT and positive symptoms (i.e., delusions
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and hallucinations). This suggests that the strategy-based learning and memory variables
used in our own analyses may not be predictive of positive symptoms (i.e., psychosis),
but in fact may be related to negative symptoms. In support of this hypothesis,
significant correlations were found between the Thought Disorder, Anergia, and
Disorganization Factor Scores, as well as the Total Score, of the Brief Psychiatric Rating
Scale and all of the non-strategy-based and a majority of the strategy-based learning and
memory variables. This suggests that the presence of positive symptoms may not be the
only factors we need to be considering.
In contrast, Vaz and Heinrichs (2002) found in the same sample that fewer words
recalled on CVLT Trials 1-5 were associated with greater positive, or psychotic,
symptoms. Overall, these findings suggest that while some variables may successfully
predict positive symptoms, others may not be associated with positive symptoms and
may be more strongly predictive of negative symptoms. Unfortunately, our study used a
combination of these variables in an attempt to differentiate between individuals
experiencing positive (i.e., psychotic) symptoms, and those that were not experiencing
such symptoms. Therefore, these findings provide encouragement for our own research,
in that the search for variables that consistently differentiate between psychiatric patients
suffering from psychosis and those not suffering from psychosis obviously still has
strides to make before consistently predictive variables are identified.
A final potential reason for our unexpected results is that neurocognitive factors
other than verbal and/or visual learning and memory may be the differentiating factor(s)
between psychiatric patients with and without co-occurring psychotic features. Previous
research, for example, has yielded evidence of impairments in domains such as working
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memory (e.g., Glahn et al., 2006) and executive functioning (e.g., Allen, Randall, Bello,
Armstrong, Frantom, & Kinney, in press) as successfully differentiating between such
individuals. Whether or not deficits in these domains could also directly or indirectly
affect verbal and/or visual learning and memory performance is yet to be determined.
Taking these hypotheses and previous and current research findings into
consideration, ideas for future research include replicating this study with a few
alterations in protocol. For example, future studies should include only individuals with
bipolar I disorder. In this manner, the identification of between-group differences can be
more confidently attributed to differences in the presence of psychosis (i.e., BP+ vs. BP-),
rather than differences in the presence of manic, hypomanic and/or depressed episodes
(i.e., BPI vs. BPII). Future research could also focus on obtaining a more representative
sample of BP, including some individuals who exhibit lower functioning.
It may also be beneficial to include a greater variety of verbal and visual tasks in
future assessment batteries in addition to those included in this study, especially given the
consistency of identification of verbal learning and memory impairments in individuals
with bipolar disorder, and the well-founded hypothesis that bipolar disorder is associated
with right hemispheric deficits, with the right hemisphere thought to be associated with
visual and spatial information processing. The inclusion of tasks which tap into the
working memory aspect of verbal and visual learning and memory may additionally
allow for the identification of differences in neurocognitive performance in individuals
with and without psychosis.
Although research to date has included only limited evidence in support of a
spectrum of severity of neurocognitive deficits such as that posited in our own study (i.e.,
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SZ < BP+ < BP- < NC), our findings demonstrate a lack of support for this hypothesis
remain surprising. A review of prior research led us to hypothesize that differential
verbal and visual learning and memory impairments may be the neurocognitive link
between these groups of individuals. The presence of psychosis in most individuals with
schizophrenia, as well as in a subset of individuals with bipolar disorder, certainly
suggests that the two disorders are related. If this is a valid hypothesis, then similarities
in neurocognitive deficits may not only present, but should be identifiable. It is our hope
that future research may be more successful in pinpointing these deficits, and thus in help
to delineate how to best diagnose and treat these often devastating psychiatric illnesses.
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APPENDIX 1
DEMOGRAPHIC QUESTIONNAIRE
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Demographic Questionnaire
Please answer the following questions completely and honestly. All of your responses
will remain confidential.
1.

Birth Date

/
Month

/
Day

Year

2. Gender Male Female
3. Ethnicity/Race:

Asian American

American Indian/Alaska

African American

Hawaiian/Pacific Islander

Hispanic/Latino

Biracial

Caucasian

Other

Native

4. Highest Level of Education Completed
5. Marital Status:

(Years)

(Months)

Married

Widowed

Divorced

Remarried

Separated

Never married

6. Current Occupation
7. Usual living arrangements (past 3 yr.):
With partner and children

With partner alone

With children alone

With parents

With family

With friends

Alone

Controlled environment

No stable arrangements

Other

8. How many children do you have?
9. Have you ever been homeless?

Yes No

10. Do you have a twin? Yes No
11. Are you left handed, right handed, or ambidextrous? Left Right Ambidextrous
HEALTH-RELATED QUESTIONS

12. Are you color-blind? Yes No
13. Do you have diabetes? Yes No
14. Is your vision corrected (glasses/contacts)? Yes No
Are you wearing them now? Yes No

15. Do you have severe visual impairments, such as cataracts or glaucoma? Yes No
16. Do you have any hearing loss (hearing aid)? Yes No
17. Have you ever or do you now have seizures? Yes No
18. Have you ever had a head injury (e.g., automobile accident, fall, sports injury)? Yes No
19. Have you ever been unconscious? Yes No
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If so, for how long?

20. Do you have any medical conditions? Yes No

(please describe)

21. Do you have any neurological disorders? Yes No
22. Do you have a learning disability? Yes No
Has this been formally diagnosed? Yes No

Diagnosis:

23. Have you ever received ECT treatment? Yes No
24. Have you ever received psychosurgery? Yes No
25. How many times have you been hospitalized for a psychiatric reason:
26. How many months since your last mood episode:
27. Do you smoke?

Yes No

a.

Cigarettes?

Yes No

b.

Cigars / Pipes?

Yes No

c.

Chewing tobacco?

Yes No

d.

How many do you smoke per day?

28. When were you were born:
a.

Were you born full term? Yes

No

Don’t Know

i. If premature, how many months was the pregnancy?
b.

Were there any obstetric complications? Yes

c.

Was your mother exposed to anything during her pregnancy (e.g., disease,
toxins, alcohol, etc.)? Yes

No

No

Don’t Know

Don’t Know

d.

Was your birth normal (e.g., head first, natural birth)? Yes

e.

Did your mother smoke when she was pregnant? Yes

No

No

Don’t Know

Don’t Know

FAMILY HISTORY QUESTIONS
Please complete these questions concerning your family. Please DO NOT list any specific
names or identify any specific person in your answers.

29. Does anyone in your family have a mental disorder? Yes No
30. Do you have any first degree relatives (e.g., mother, father, brother, child) with a mental
disorder? Yes No
a.

What is the disorder?
i.

Schizophrenia

Yes No

ii.

Affective disorder

Yes No

iii.

Alcoholism

Yes No

iv.

Parkinsonism

v.

Movement disorder

Yes No

vi.

Schizophrenia spectrum disorder

Yes No

vii.

Other

Yes No

31. Do you have any second degree relatives (e.g., aunt, uncle, grandmother, grandfather) with a
mental disorder? Yes No
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a.

What is the disorder?
i.

Schizophrenia

Yes No

ii.

Affective disorder

Yes No

iii.

Alcoholism

Yes No

iv.

Parkinsonism

v.

Movement disorder

Yes No

vi.

Schizophrenia spectrum disorder

Yes No

vii.

Other

Yes No

32. Please list any medications you are currently taking
Current Medications

Dosage
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Date Started
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